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Abstract
Pseudomonas aeruginosa strain PA14 is an opportunistic human pathogen capable of infecting a wide range of organisms
including the nematode Caenorhabditis elegans. We used a non-redundant transposon mutant library consisting of 5,850
clones corresponding to 75% of the total and approximately 80% of the non-essential PA14 ORFs to carry out a genome-
wide screen for attenuation of PA14 virulence in C. elegans. We defined a functionally diverse 180 mutant set (representing
170 unique genes) necessary for normal levels of virulence that included both known and novel virulence factors. Seven
previously uncharacterized virulence genes (ABC transporters PchH and PchI, aminopeptidase PepP, ATPase/molecular
chaperone ClpA, cold shock domain protein PA0456, putative enoyl-CoA hydratase/isomerase PA0745, and putative
transcriptional regulator PA14_27700) were characterized with respect to pigment production and motility and all but one
of these mutants exhibited pleiotropic defects in addition to their avirulent phenotype. We examined the collection of
genes required for normal levels of PA14 virulence with respect to occurrence in P. aeruginosa strain-specific genomic
regions, location on putative and known genomic islands, and phylogenetic distribution across prokaryotes. Genes
predominantly contributing to virulence in C. elegans showed neither a bias for strain-specific regions of the P. aeruginosa
genome nor for putatively horizontally transferred genomic islands. Instead, within the collection of virulence-related PA14
genes, there was an overrepresentation of genes with a broad phylogenetic distribution that also occur with high frequency
in many prokaryotic clades, suggesting that in aggregate the genes required for PA14 virulence in C. elegans are biased
towards evolutionarily conserved genes.
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Introduction
Pseudomonas aeruginosa, an opportunistic Gram-negative human
pathogen, is one of the leading causes of hospital-acquired
infections. In the context of a breakdown in host defenses, it is
capable of infecting a plethora of tissue types, causing both acute
and chronic infections. Burn victims as well as immunocompro-
mised, mechanically ventilated, and cystic fibrosis (CF) patients are
particularly susceptible to P. aeruginosa infection [1]. Over the last
few decades, a steady increase in drug resistant P. aeruginosa strains
has made antibiotic treatment more difficult [2]. In part because
no new antibiotics effective against P. aeruginosa are imminently
available as treatment options, the pressing need for drugs to fight
this pathogen has focused study on its virulence factors as potential
drug targets, and more generally energized a search for novel anti-
infectives [3–5].
One likely reason that P. aeruginosa is a common nosocomial
pathogen is because it is capable of thriving in a wide variety of
environmental niches, including surfaces in hospital rooms, water,
soil and plants [6]. Consistent with its ecological ubiquity, P.
aeruginosa has a relatively large genome that presumably promotes
survival in diverse habitats. In addition to inhabiting a wide variety
of ecological niches, P. aeruginosa is also a multi-host pathogen,
capable of infecting hosts as divergent as amoebae, plants, insects,
flies, nematodes, and mice [7–13]. Progress in fighting P. aeruginosa
infections will be aided by a fundamental understanding of the
myriad ways that P. aeruginosa can survive in different environ-
ments and cause disease in diverse hosts.
Our laboratory has developed a Pseudomonas aeruginosa -
Caenorhabditis elegans infection-based model for studying host-
pathogen interactions that is genetically tractable from both the
perspectives of the host and the pathogen. This model (referred to
as ‘‘slow-killing’’ or SK), which primarily utilizes P. aeruginosa strain
PA14 [8], requires live bacteria and a set of bacterial virulence
factors that distinguish it from rapid toxin-mediated PA14 killing
of C. elegans (‘‘fast killing’’ or FK) that occurs on high osmolarity
media [12,14]. Under standard laboratory conditions [15], C.
elegans animals have a normal lifespan of approximately two weeks
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OP50 does not accumulate in the C. elegans intestine during the
first few days of life. In contrast, when C. elegans are transferred at
the L4 larval stage from E. coli OP50 to a lawn of P. aeruginosa
strain PA14, the animals die in two-three days [12]. A few PA14
cells initially accumulate in the anterior and posterior portions of
the nematode intestine, then over the course of one to two days
bacteria spread throughout the intestine and the intestinal lumen
becomes severely distended with a corresponding reduction in
volume of the intestinal epithelial cells. Ultimately, PA14 cells
move across the intestinal epithelial barrier destroying tissue, but it
is not known whether tissue invasion is required for killing [16].
C. elegans rapidly responds to the presence of pathogenic PA14
by enhancing the transcription of hundreds of genes including a
number of predicted secreted proteins (C-type lectins, CUB-
domain containing proteins, ShK toxins) that may have antimi-
crobial or detoxifying activity [17,18]. Two of the major classes of
PA14 response genes, C-type lectins and CUB-like domain
containing proteins, also play a role in mammalian innate
immunity [19–21]. In C. elegans, many immune response genes
are regulated by the PMK-1 p38 mitogen-activated protein kinase
(MAPK), the terminal MAPK in an evolutionary conserved
signaling cassette required for defense against pathogens in both
nematodes and mammals. Approximately 25% of the C. elegans
genes regulated by PMK-1 are also induced in response to P.
aeruginosa PA14 [18] and C. elegans p38 MAPK pathway mutants
exhibit enhanced sensitivity to PA14 as well as a variety of other
bacterial and fungal pathogens [22–24].
Several hundred genes have been implicated in P. aeruginosa
virulence based on data obtained from a wide variety of host
infection models (Pseudomonas.com). Many of the well-studied P.
aeruginosa virulence-related factors participate directly or indirectly
in physical interactions with the host cell and/or host proteins,
including secretion systems (type II, type III, type VI) and
associated effectors (including ExoT, ExoU, ExoS, ToxA, phos-
pholipase C, and alkaline protease), flagella, and structures
involved in attachment to host cells such as type IV pili. Other
recognized virulence factors include those involved in quorum
sensing (AHL and PQS systems), iron acquisition (pyochelin,
pyoverdine), small molecule/toxin synthesis (phenazines, hydrogen
cyanide), alginate, LPS, and biofilm. Not all of these classes of
virulence-related factors play a significant role in P. aeruginosa strain
PA14 virulence in C. elegans; for example, the Type III secretion
system and its associated virulence effectors have been shown to
play no detectable role in nematode killing, in contrast to playing
key roles in pathogenesis in mammals and insects [25]. However, a
variety of P. aeruginosa PA14 virulence factors required for killing C.
elegans in the SK infection model are also required for full
pathogenesis in mammalian models, including the quorum sensing
regulators LasR and RhlR, the two component regulator GacA,
the alternate sigma factor RpoN, the periplasmic protease MucD,
and the phosphoenolpyruvate-protein phosphotransferase and
transcriptional regulator PtsP [13,26–29]. Additionally P. aeruginosa
virulence-related factors involved in LPS biogenesis and type IV
pilus assembly and function also play a role in both mammalian
and C. elegans hosts [30–33].
A common theme that has emerged from the study of bacterial
virulence in a wide variety of pathogens and hosts is an association
linking virulence-related genes with regions of genomic plasticity,
including genomic pathogenicity islands (PAIs) [34], so-called
‘‘replacement islands’’ harboring the pyoverdine [35] and O-
antigen biosynthetic loci [36], and plasmids [37]. These findings
indicate that horizontal gene transfer has played an important role
in the evolution of virulence. For example, phylogenetic analysis of
three sub-families of the type III effector HopZ in the plant
pathogen Pseudomonas syringae, suggested that at least two were
acquired by P. syringae from disparate donors [38]. Analysis of the
occurrence of virulence factors across many pathogen genomes
has suggested that there is an overrepresentation of virulence
factors on genomic islands [39], and two virulence factor-
containing pathogenicity islands, PAPI-I and PAPI-II, have been
identified in P. aeruginosa [40].
Although there are many published examples linking virulence-
related factors to putative pathogenicity islands, a preliminary
study from our laboratory showed that the presence of genes
occurring in the highly virulent strain PA14, but not in the less
virulent strain PAO1, could not be correlated with increased
virulence across a wider sampling of strains, suggesting that
virulence is a combinatorial and multifactorial product of the
interactions of many potential virulence factors [32]. These data
were seemingly at odds with the expected over-representation of
virulence factors in strain-specific regions such as genomic islands,
but were not definitive because only a limited set of virulence
factors were available for analysis. Further, comparison of the
sequences of five pathogenic P. aeruginosa strains suggested that
virulence was primarily encoded by a core P. aeruginosa genome
[41], a set of genes shared by all strains, and not the auxiliary
genome defined by regions of genomic plasticity that are strain-
specific. An unbiased comprehensive list of P. aeruginosa virulence
factors required to cause disease in C. elegans would allow us to
better understand what genes are the major contributors to
virulence and whether these genes are primarily located in regions
of genome plasticity or not. We considered this question worthy of
investigation because it seemed likely to us that the virulence
factors of an opportunistic multi-host pathogen might as a group
be distinct from the virulence factors of host-specific pathogens.
We report here the results of a genome-wide screen using a
previously constructed non-redundant PA14 transposon library
consisting of 5850 members that represents insertions in approx-
imately 80% of the non-essential ORFs in P. aeruginosa strain PA14
Author Summary
Pseudomonas aeruginosa is an opportunistic human
pathogen that can also infect a wide range of model
organisms, including the nematode Caenorhabditis ele-
gans. To identify P. aeruginosa genes that play key roles in
the pathogenic process, we performed a screen for
mutants that exhibited reduced ability to kill C. elegans
using a previously constructed non-redundant library
representing approximately 80% of the non-essential P.
aeruginosa PA14 genes. We defined a functionally diverse
set of 180 P. aeruginosa mutants (representing 170 unique
genes) necessary for normal levels of virulence that
included both known and novel virulence factors. The
major contributors to P. aeruginosa virulence in the C.
elegans infection model were not secretion systems or
their corresponding effectors, but rather regulators (par-
ticularly ones that are involved in quorum sensing) and
genes likely to play key roles in survival of P. aeruginosa
within the host intestine. Moreover, these putative P.
aeruginosa virulence genes are neither overrepresented in
strain-specific regions nor in horizontally acquired geno-
mic islands and furthermore tend to have orthologs that
are widely distributed across sequenced prokaryotic
species. These data underscore the diversity of pathways
involved in virulence, and especially the importance of
highly conserved genes for P. aeruginosa virulence in the C.
elegans host model.
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vivo using a number of different technologies and infection models
have been limited by the complexity and redundancy of mutant
collections or screening procedures [13,26,27,43–51]. We exam-
ined the genes identified in this genome-wide screen for their
functions, presence on putative and characterized genomic islands,
and their phylogenetic distribution across prokaryotes. We
demonstrate that the major genes contributing to PA14 virulence
in C. elegans are not enriched on genomic islands, are not PA14 or
P. aeruginosa specific genes, and may in fact be biased for ancient
genes common to many other prokaryotic species.
Results
Genome-Wide Screen for PA14 Mutants Attenuated in C.
elegans Killing
Primary screen. A non-redundant (NR) library of MAR2xT7
transposon insertion mutants representing approximately 75% of
the total and 80% of the non-essential ORFs in P. aeruginosa PA14
was screened for attenuation of virulence in an infection-based
model of C. elegans killing (see Figure 1, Figure S1 and Table S1 for
an overall scheme of the screen). In this infection assay, called
‘‘slow killing’’ (SK), nematode death requires live bacteria and
correlates with accumulation of bacteria in the nematode intestine
[12,16]. Ideally, we would have screened the entire non-redundant
transposon library using the SK assay, but the relatively large
number of mutants (5850) in the library made direct quantitation
of killing kinetics impractical for a primary screen. In previous
work [13] and in new experiments with known virulence-
attenuated mutants (Figure S2), we observed that the quantity
and maturity of the brood size of an infected hermaphroditic
worm is generally inversely correlated with the virulence of the
infecting PA14 strain. Under our standard assay conditions, wild-
type PA14 kills C. elegans rapidly enough to dramatically diminish
the number of progeny produced, and the few larvae that hatch do
not reach maturity. However, PA14 mutants with reduced
virulence (such as gacA, lasR, mucD; Figure S2) allow the C. elegans
hermaphrodites to produce a significant brood that is able to reach
adulthood and in turn become gravid, often consuming the entire
bacterial lawn. Based on these data, we concluded that we could
use PA14-mediated nematode brood size reduction, a much less
time consuming assay than monitoring death of a population of
worms, as a proxy for PA14-mediated killing.
A total of 5,754 mutants (the complete 5,850 PA14 NR library
minus one 96-well plate consisting of previously characterized
slow-growing mutants) was screened twice on SK agar in standard
6-well assay plates for mutants that permitted an increase in C.
elegans progeny number or allowed the brood to mature to
adulthood when compared to wild-type PA14. In this primary
screen, 399 mutants (corresponding to 368 genes and three
mutants in intergenic regions) were identified as potentially
attenuated in virulence (Figure 1, Figure S1 and Table S1). From
the set of 399 putative virulence-attenuated mutants, 86 auxotro-
phic or growth-defective mutants corresponding to 74 genes
(Table S2) were identified by replica plating on minimal medium.
Some but not all of the 86 auxotrophic mutants formed noticeably
thin lawns on the SK agar plates. We reasoned that the 86 mutants
with fundamental growth defects were not relevant to our study of
virulence and we eliminated them from future studies. This left
313 putative virulence-related mutants corresponding to 294
distinct genes and three mutants in intergenic regions (Table S3).
Secondary screen. The 313 putative PA14 virulence-related
mutants that did not appear to be dependent on the addition of
amino acids or nucleotides for growth on minimal media were
re-tested using C. elegans slow killing assays. Specifically, the
survival of 60–80 wild-type N2 Bristol worms was quantified at
two or three different time points following manual transfer of
individual worms from E. coli OP50 to a lawn of each PA14
mutant. In addition, the number of progeny produced was scored
after four days. Each batch of mutants tested in the secondary
screen included two known attenuated mutants, the strongly
avirulent quorum sensing regulatory mutant lasR and the
moderately attenuated type IV pilus protein mutant pilA. The
mutants from the secondary screen were ranked with respect to
these controls. About 63% (198) of the 313 non-auxotrophic
mutants from the primary screen exhibited an attenuated killing
phenotype or increased brood size in the secondary screen
(Figure 1, Table S1). The insertion sites of MAR2xT7 in the
attenuated mutants from the secondary screen were re-sequenced
to verify their identity and the mutants were rescored for readily
apparent growth defects in overnight cultures or on plates. As a
result, 18 mutants that had either incorrectly annotated sequence
or were slow growing were removed from the list. Of the 180
remaining virulence-attenuated mutants from the secondary
screen (representing 170 genes and one mutant in an intergenic
region), 34 were strongly attenuated (similar to lasR), 76 were
moderately attenuated (greater than or equal to pilA), and 70 were
weakly attenuated (less than pilA but allowing greater parental or
progeny survival than wild-type PA14) (Table S4).
Previously in our laboratory, 17 PA14 mutants were shown to
exhibit an attenuated phenotype in a standard C. elegans SK assay.
Of these 17, 15 were identified in relatively small-scale forward
genetic screens (aefA, lasR, mtrR, ptsP, gacA, gacS, PA14_03370,
ORF_10 (PA14_23420), ORF_11 (PA14_23430), PA14_27680
(GID6172), PA14_27700 (GID6170), pilC, PA14_59010,
PA14_59070 and pilW) and two by a candidate gene approach
testing predicted virulence factors (rpoN, mucD). Of these 17 genes,
16 are represented by mutants in the PA14 non-redundant library
(lasR is absent). One of these 16, rpoN, grows very slowly under our
conditions and was not assayed. Thus 15 previously identified
mutants could potentially have been recovered in the screen of the
non-redundant library. In fact, nine of these 15 previously
identified mutants were identified in the primary screen and eight
of these nine also scored as positives in the secondary screen
(strongly attenuated ptsP, gacA, gacS, and PA14_27700 (GID6170),
moderately attenuated i.e. close to the attenuation of pilA,
ORF_11, mucD, and PA14_27680 (GID6172), and very weakly
attenuated PA14_03370). At least four of the remaining seven
previously identified virulence-related genes (ORF_10, pilC,
PA14_59010, PA14_59070) that we did not isolate in the
secondary screen exhibited virulence-related phenotypes approx-
imately equal to pilA, which has a phenotype at the lower limit of
sensitivity for recovery in the progeny-based screen (note an ORF-
10 mutant was recovered in the primary screen but not the
secondary). Although pilC and ORF_10 were not recovered in the
secondary screen, other type IV pilus and O-antigen synthesis
mutants (pilF, pilW, pilU and ORF_11) were identified. Based on
these data, we conclude that the genome-wide screen that we
carried out to identify PA14 virulence-related factors was
successful in identifying the majority of the virulence-related
mutants in the non-redundant library with strong killing-attenu-
ated phenotypes, but that many potential mutants with relatively
weak attenuated phenotypes were probably overlooked.
We compared the genes identified in our screen to a set of 241
P. aeruginosa strain PA14 virulence-related genes downloaded from
the Virulence Factor Database (VFDB). VFDB is, a compilation of
virulence factors from a wide variety of pathogens in numerous
host systems that includes virulence factor sets for PA14 and for
Screen for P. aeruginosa Virulence in C. elegans
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The VFDB set for PA14 incorporates well-studied virulence
factor classes, most abundantly those involved in adherence/
motility (flagella, type IV pilus, LPS), alginate, rhamnolipids, iron
uptake (pyochelin and pyoverdine), quorum sensing, global
regulators (GacA/GacS), proteases (alkaline protease, LasA,
LasB), lipases (PlcH, PlcN), secretion systems and associated
effectors (type III, type VI), pyocyanin pigment and toxins (ToxA,
hydrogen cyanide). The degree of overlap between the VFDB
genes and those identified in our screen increased between the
primary and secondary round of screening, with VFDB genes
constituting 10.2% (30 of 294) of the genes identified in the
primary screen and 11.8% (20 of 170) of the genes identified in
the secondary screen (Figure S3).
The collection of avirulent secondary positive hits does
not exhibit a strong functional bias. The 170 genes
(represented by 180 mutants) from the secondary screen were
grouped by the 27 functional protein classes used in the annotation
of the PA14 genome (http://ausubellab.mgh.harvard.edu/cgi-
bin/pa14/annotation/statistics.cgi) and the fraction of genes in
each functional class was compared to that of the total PA14
genome (Table S4). Only one functional class, LPS and capsule
biosynthesis, was marginally statistically overrepresented (p-
value=0.013) after FDR correction. In addition, the 170 genes
were mapped onto the KEGG pathway database to determine
whether particular biochemical pathways were enriched and were
categorized by GO term with DAVID. Neither the KEGG
pathway nor the GO term analysis revealed any significant
overrepresentation of pathways or GO terms.
The PA14 secondary virulence screen did not enrich for
known secretion systems or secreted effectors. Canonical
virulence factors such as those present in VFDB are enriched in
extracellular proteins (10% in VFDB vs. a little over 1% in the
PA14 genome and NR mutant set) and in various secretion
Figure 1. Pipeline of screen for PA14 virulence-attenuated mutants in C. elegans. The three screening steps for identification of P.
aeruginosa PA14 virulence-attenuated mutants are outlined; details of the screens are presented in the Materials and Methods and the text. The
number of mutants obtained after each round of screening, as well as those removed from the pool for various reasons, is shown. Note that the 313
mutants identified in the primary screen and the 180 from the secondary screen represent 294 and 170 unique genes respectively because some
genes were represented by multiple mutants, and a small fraction of mutants were in intergenic regions (see text). In the tertiary screen a single
mutant defined each gene.
doi:10.1371/journal.ppat.1002813.g001
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genome). In contrast, mutations with consistent or strong
phenotypes in any of the known secretion systems or effectors
were significantly underrepresented in our genome-wide screen.
Among 62 documented PA14 secreted proteins and their
chaperones [53] (PA14 database at http://ausubellab.mgh.
harvard.edu/cgi-bin/pa14/annotation/start.cgi), 55 of which
correspond to mutants in the PA14 NR Set, only one was also
found in the 180 virulence-attenuated mutant set from the
secondary screen. Similarly, although our primary screen
identified 15 of 97 NR set mutants annotated to be secretion
apparatus proteins or their chaperones (type II, III, V and VI),
only six of these were retained after the secondary screen. Three of
the secretion apparatus loci mutants isolated in the secondary
screen (type II secretion loci xcpT, xcpZ and secB) exhibited only
slight attenuation of virulence and three had moderate attenuation
of virulence roughly equivalent to the pilA mutant control (typeII
tatC and type VI HSI-I locus clpVI and type VI HIS-II fha2).
Although we isolated two type VI mutants in our screen it is
unclear what this means as many of the type VI structural loci
were not identified, and two large deletions of type VI HSI-II and
HIS-III had little effect on virulence (data not shown). These data
do not strongly implicate a particular secretion system as
predominant in PA14 virulence in C. elegans and are consistent
with previous work from our lab, which showed that the type III
secretion system mutants had no detectable attenuation of
virulence in C. elegans [25]. On the other hand, the failure to
observe a phenotype with the secretion defective mutants may be a
consequence of built-in redundancy.
Comparison of the 170 P. aeruginosa putative virulence
genes identified in C. elegans with genes required for
virulence in a rat chronic infection model. In order to
evaluate the degree to which virulence genes from our screen
represent putative conserved virulence determinants, we com-
pared the 170 genes identified in our secondary screen with the
largest available set of genes identified in another unbiased screen,
a negative signature tagged mutagenesis (STM) selection for P.
aeruginosa mutants defective in virulence in a rat chronic respiratory
infection model [46]. It is notable that like the 170 genes identified
in our screen, and in contrast with the VFDB set, the 148 P.
aeruginosa genes identified by Potvin et al (2003) by STM also
appear as a group to possess a broad distribution across all
functional classes. The P. aeruginosa mutant set identified in the rat
chronic infection model exhibits an underrepresentation of
secreted proteins and secretion systems and includes a number
of auxotrophic mutants and many mutants in genes with
enzymatic functions not previously linked to pathogenesis,
reminiscent of the mutants identified in C. elegans. Only five genes
identified in the rat infection model were also found in the 170
gene set from our secondary screen and only one of these was also
found in the VFDB (Figure S4). A number of well-studied P.
aeruginosa virulence factors, required for slow killing in C. elegans
and in some mammalian infection models, including gacA, lasR,
rhlR, ptsP, mucD, and rpoN, are absent from the rat chronic infection
set. We do not know if this reflects a difference between chronic
and acute infections, nor whether the C. elegans model is more
analogous to acute or chronic infection in mammals. These data
suggest that genes required for virulence under a particular set of
circumstances are highly dependent on host model, infection site,
and most likely phase of infection.
Tertiary screen. The relatively large number of positive
mutants (180 corresponding to 170 genes) from the secondary
screen made it necessary to prioritize mutants for further
characterization. A subset of 58 mutants/genes was selected based
on strength of attenuation, annotation (biased toward regulators
and mutants with functions previously implicated in virulence),
whether they were in putative operons or functionally grouped
with other attenuated mutants, and whether they exhibited normal
doubling times (see Materials and Methods). These mutants (Table
S5) included 31 mutants with strongly attenuated virulence similar
to that of the lasR quorum sensing mutant (34 such mutants were
isolated but gacA, ptsP and pepP were represented by two mutants
each and a single allele of these three genes was carried through
the tertiary screen), 22 mutants with moderately attenuated
virulence (less attenuated than lasR but equal to or more
attenuated than pilA), and five weakly attenuated mutants (less
attenuated than pilA).
In the tertiary screen, each of the 58 selected mutants was
subjected to SK assays using 100–150 fer-15(b26)II;fem-1(hc17)IV
worms and the time to 50% survival was determined. Sterile fer-
15;fem-1 worms were used in these assays to avoid production of a
brood that would complicate the scoring of death of the parental
worms. fer-15;fem-1 animals, while slightly more resistant to PA14
than N2 worms, have previously been used to study the
transcriptional response of C. elegans to PA14 [18]. Importantly,
wild-type N2 worms and fer-15;fem-1 worms exhibit comparable
relative susceptibilities to a gacA mutant [18]. Four mutants
(PA4296, rcsC, bkdA1, and norB) did not re-test as avirulent in the
tertiary assay, three (in ORFs PA2658, PA14_4560 and PA4745)
exhibited impaired growth in LB overnight cultures that had been
previously overlooked and two mutants were removed based on
ambiguity as to which ORF they were inactivating (mutants
#38436 and #5691) (Table S5). Thus, the tertiary screen
substantiated the avirulent phenotype of 49 of the 58 mutants.
Use of the Master Transposon Library to Verify
Phenotypes and Examine the Genomic or Functional
Context of Putative Virulence-Attenuated Mutants
Multiple transposon alleles confirm avirulent
phenotypes. One of the bottlenecks in a large-scale screen
such as the one described in this paper is verification of the mutant
phenotypes. In general, the gold standard to correlate phenotype
with genotype is to generate an in-frame deletion mutant and then
complement the mutant in trans to establish that the phenotype
observed is due to the defect in the identified gene. Because the
goal of our screen was to obtain an overview of the major factors
utilized by PA14 to infect and kill C. elegans, we were interested in
characterizing a large collection of mutants. Generation of in-
frame deletions for all the genes of interest was prohibitively time-
consuming. As an alternative, we reasoned that by examining
multiple independent MAR2xT7 insertion mutations in candidate
virulence-related genes, as well as insertions in adjacent genes
within putative operons, we could: a) verify the avirulent
phenotype of the original mutation, b) reduce the likelihood that
the avirulent phenotype was due to polar effects of the original
transposon insertion on downstream ORFs, and c) eliminate the
possibility that second-site mutations were responsible for the less
virulent phenotype. The NR PA14 library of 5,850 mutants was
selected from more that 24,000 sequenced MAR2xT7 transposon
insertion mutations and on average each gene in the NR library is
represented by 4.3 transposon insertions in this ‘‘master’’ library of
24,000 mutants [42].
Among the mutations in the 49 genes that re-tested as avirulent
in the tertiary screen, there were 44 genes for which there was
more than one corresponding transposon insertion. (However,
three genes for which multiple insertion alleles existed, gacS, pilF
and aruD, were only tested with single alleles. gacS and pilF had
been previously implicated in virulence in C. elegans and in the case
Screen for P. aeruginosa Virulence in C. elegans
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attenuated (Figure 2 and Figure 3). A total of 72 additional
insertion mutants corresponding to 41 of the 49 genes were tested
in SK assays. These assays resulted in the elimination of eight
genes (PA2089, PA0902, PA1032, PA0533, PA4016, clpS, sltB1
and pvdD) from further consideration because the additional
transposon insertions in these genes did not cause an attenuated
killing phenotype (representative data are shown for clpS (Figure 4)
and PA4016 (Figure 5B). In the case of clpS, for example, in
contrast to the virulence-attenuated clpS NR allele mutant
ID#34203 isolated in the screen (LT50 mutant/LT50 wild-type
(WT) PA14=1.66), three additional independent alleles of clpS all
exhibited killing kinetics similar to WT PA14 (LT50 mutant/LT50
WT PA14=1.11, 1.10 and 0.98 respectively) suggesting that the
phenotype of mutant #34203 was aberrant.
DexoU, a potential sensitized genetic background. We
noticed that in 4/8 cases where the phenotype of the mutant
identified in the screen was not recapitulated by additional alleles
(putative transcriptional regulator PA0533 mutant #22525,
probable penicillin amidase PA1032 mutant #6114, hypothetical
protein PA4016 mutant #22683, and pvdD PA2399 mutant
#5205), the original allele was in a DexoU background, which
carries an in-frame deletion of the type III effector ExoU [42]. The
DexoU mutant behaved similarly to wild-type PA14 in nematode
killing assays (Figure 5B, D and [25]). The observation that 50% of
the mutants in which the original phenotype did not recapitulate
with multiple alleles also contained a DexoU mutation despite the
fact that less than 4% of the transposon insertions in the NR
library are in the DexoU background suggests that the mutation in
exoU might create a sensitized genetic background to identify other
putative virulence factors. In support of this conclusion, two alleles
of gshB (#42799 identified in our screen and #28669 from the
master library) exhibited modest virulence attenuation (LT50
mutant/LT50 WT PA14=1.25 and 1.30 respectively), whereas a
third gshB insertion allele in the DexoU background (#6613)
showed a considerably stronger attenuated phenotype (LT50
mutant/LT50 WT PA14=1.68) (Figure 5D). Construction of a
series of double mutants carrying DexoU (or perhaps other
Figure 2. 41 PA14 genes required for virulence in a C. elegans infection based killing model. The ratio of nematode survival on mutant
PA14 to that on wild-type PA14 (mutant LT50/WT LT50) is presented for 41 mutants identified after three rounds of screening as well as for the known
virulence-attenuated mutants, lasR and pilA. The time to 50% death (LT50) was calculated using a non-linear regression based on the Hill equation
(Prism 5.0). 100–150 animals were tested in each experiment. Error bars represent the SEM of the ratios derived from at least two different
experiments (lack of error bars indicates that the mutants for known virulence factors gacA, ptsP and vfr were tested only once). Red bars depict the
ratio of the LT50 of lasR or pilA to WT PA14. The lasR and pilA mutants were generated previously (see Materials and Methods); there are no alleles of
lasR or pilA in the NR library. The number of alleles tested with an avirulent phenotype is indicated by a number below the graph: 1 indicates that a
single allele was tested but that there exist multiple alleles in the master transposon library, S indicates only a single allele was available in the library.
Genes that are predicted to be in operons are indicated (Y=yes, N=no). Genes in a single operon are represented in the same color and an underline
designates that other genes within the same operon were tested for their role in virulence.
doi:10.1371/journal.ppat.1002813.g002
Screen for P. aeruginosa Virulence in C. elegans
PLoS Pathogens | www.plospathogens.org 6 July 2012 | Volume 8 | Issue 7 | e1002813mutations in the type III secretion apparatus or effectors) and
mutations in other virulence loci would help to clarify the role of
PA14 ExoU in pathogenesis of C. elegans.
Features of 41 PA14 tertiary set genes required for
virulence in C. elegans. Figure 2 shows the relative virulence
of the 41 mutants (corresponding to 41 genes) out of the 58 tested
whose phenotypes were confirmed in the tertiary screen (Table S5,
Table S6). Of the 41 genes, 21 have been previously implicated in
P. aeruginosa virulence in at least one host and an additional 4 genes
have been identified as virulence-related in other pathogens
(Table 1). Thus 20 of the 41 (49%) genes identified in our screen
are novel P. aeruginosa virulence-related genes. None of these 41
mutants exhibited significant growth defects and in 33 cases, the
virulence-related phenotypes were verified by two or more
independent MAR2xT7 transposon insertions. In Figure 2, the
ratio of the time to 50% nematode survival on each mutant to the
50% survival time on wild-type PA14 is presented (the average
value of the ratio from multiple experiments is shown in most
cases). The mutants for which killing assays were not repeated
(gacA, ptsP, vfR) had been previously demonstrated to be virulence-
attenuated in C. elegans in published studies [13,54]. The ratios of
50% survival time of the positive lasR and pilA controls to WT
PA14 were 1.63 (SEM=0.08 for 10 independent experiments) and
1.22 (SEM=0.04 for 10 independent experiments), respectively,
and are shown as red bars in Figure 2. Among these 41 genes, five
(indicated by ‘‘S’’ in Figure 2; pchH, lysC, PA1592, aruG, fha2) were
represented by a single allele in the master library and the
avirulent phenotypes corresponding to these insertions could not
be verified by an independent insertion allele. The data shown in
Figure 2 are for the mutant allele identified in the initial screen
from the NR library (in the case where two alleles were identified a
single allele was chosen). Examples of C. elegans survival curves
(representative curves of assays repeated at least twice) from which
the data in Figure 2 are derived are shown for clpA (Figure 4B),
gshB (Figure 5D), pchH and pchI (Figure 6B), and aruC, aruG, aruB,
aruD (Figure 3B). Additional survival curves are shown in the
Supporting Information for pepP (Figure S5B), PA0456 (Figure
S6B), kinB (Figure S7B), PA14_27700 (Figure S8B), PA0745
(Figure S9B), vqsR (Figure S10B) and gshA (Figure S11B).
Additional transposon mutants used to examine the role
of identified operons. In bacteria, genes that function in
common processes are frequently co-regulated in operons or
clustered in the genome. We utilized the public PA14 database
constructed in our laboratory [http://ausubellab.mgh.harvard.
edu/cgi-bin/pa14] and BIOCYC [http://biocyc.org/
PAER208963/NEW-IMAGE?object=Transcription-Units] to
Figure 3. The catabolic arginine succinyltransferase (aru)
operon is required for normal virulence in C. elegans. A) aruFGDB
is transcribed as a unit; the transcriptional regulator aruC is transcribed
separately. The aruFGDB operon encodes enzymes for the major
aerobic route of arginine utilization as an energy, carbon and nitrogen
source [56,57]. In P. aeruginosa PA01, aruE belongs to a separate
transcription unit [57]. B) MAR2xT7 insertions in aruC, aruF, aruG, aruD
and aruB all reduce the virulence of PA14. The single mutation in aruE
has normal virulence.
doi:10.1371/journal.ppat.1002813.g003
Figure 4. Multiple transposon alleles of clpA, but not clpS, are
virulence-attenuated. ClpA is the chaperone subunit responsible for
substrate recognition of the ClpAP ATP dependent protease common
to Gram-negative proteobacteria [96]. A) clpA (PA2620) is the second
gene of a two gene operon; it is preceded by clpS (PA2621), encoding a
ClpAP adaptor protein that has been shown to bind to the N-terminus
of ClpA and inhibit ClpAP degradation of some substrates while
enhancing the degradation of others [97]. B) Four different MAR2xT7
transposon insertion alleles of clpA are decreased in virulence in C.
elegans. C) Three of four MAR2xT7 insertion alleles of clpS exhibit wild-
type levels of virulence. Only the clpS mutant (#34203) identified in the
primary and secondary screens has a virulence-attenuated phenotype.
A mutant in the ClpP proteolytic subunit (#52957) was also identified in
our primary screen for virulence-attenuated mutants, but this mutant
was defective in growth on minimal media and therefore was not
analyzed further.
doi:10.1371/journal.ppat.1002813.g004
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identified were in operons, based on annotation and the proximity
and direction of transcription of adjacent genes. Of the 41 genes
shown in Figure 2, our analysis suggested that 27 are located in 22
putative operons (see Figure 2). Multiple insertion mutations in
three operons were identified in our screen, four in the aru operon
(aruC, aruG, aruD, aruB), two in a pyochelin biosynthetic operon
(pchH, pchI), and two (PA1766, PA1767) in an operon of unknown
function. Utilizing the master insertion library of 24,000 mutants,
we tested an additional 38 mutants (corresponding to 24 genes) in
11/22 of the putative operons and thereby identified six more
genes in five operons that resulted in virulence attenuation when
mutated: aruF, which is part of the aru operon; ORF_10, which
had been isolated in a previous screen and together with ORF_11
forms a predicted transcription unit involved in O-antigen
biosynthesis [32]; pqsA, which is required for synthesis of the
quinolone quorum sensing molecule located upstream in the pqsE
operon [55]; PA1218 and PA1221, which are upstream of PA1216
in an operon of unknown function; and PA4000 at the end of the
operon containing PA4005. Note that mutations in proA and nadD
directly upstream of PA4005 in the operon were identified in our
primary screen but discarded because they are auxotrophs.
Interestingly, in the case of 5/11 putative operons (containing
pepP, kinB, PA0745, clpA and fha2) for which mutations in multiple
genes were analyzed, only mutation of a single gene in the operon
resulted in an attenuated phenotype. Two genes in the final
operon examined (pchH, pchI) were identified in the primary and
secondary screens, but mutations in the other genes in this
pyochelin operon had no significant effect on virulence (Figure 6C).
It is important to keep in mind that not all the genes in each of the
operons examined were represented by MAR2xT7 insertions in the
master library.
Our finding that mutation of some but not all genes in an
operon affect virulence may indicate redundant functions (perhaps
located elsewhere in the genome) for those with no mutant
phenotype or unique roles in virulence for specific genes within the
operon. The aru operon, which encodes the catabolic enzymes for
aerobic utilization of arginine as a carbon, nitrogen and energy
source [56,57], represented an unusual case where 5/5 genes in
the aruCFDGB operon all exhibited a similar moderate attenuation
of virulence when mutated. The aru insertion mutations did not
observably affect growth of the bacteria on SK plates (although a
single mutant in aruF #56181 had somewhat reduced growth on
minimal media in the absence of nucleotides and amino acids)
suggesting that the catabolism of arginine may be important for
growth or virulence of the bacteria within the nematode.
Interestingly, mutation of aruE, which is located downstream and
adjacent to the aruFGDB operon, did not result in an avirulent
phenotype. In the P. aeruginosa strain PA01 aruE is reported to be a
separate transcription unit [57] (Figure 3).
Virulence-Related Phenotypes of Selected Mutants
Seven putative virulence-related factors, cold shock domain
protein PA0456, ABC transporters PchH and PchI, aminopepti-
dase PepP, putative enoyl-CoA hydratase/isomerase PA0745,
ATPase/molecular chaperone ClpA, and putative transcriptional
regulator PA14_27700 were chosen for further study. Mutants
corresponding to these factors (clpA, Figure 4B; pchH and pchI,
Figure 6B; pepP, Figure S5B; PA0456, Figure S6B; PA14_27700,
Figure S8B; and PA0745, Figure S9B, C) all have a strong
avirulent phenotype in C. elegans, exhibit normal growth kinetics in
vitro (Figure S12), and represent genes whose role in P. aeruginosa
virulence has not been previously characterized. The avirulent
phenotype of all these mutants was confirmed with multiple
transposon alleles except for pchH for which there is only a single
allele available. In addition, in the case of PA0745, an in-frame
deletion mutant was generated that was severely impaired in
virulence, similar to the transposon allele #37629 isolated in the
screen (Figure S9C).
Many of the genes previously identified as necessary for
virulence of PA14 in C. elegans, for example those coding for the
Figure 5. DexoU may be a sensitized background that can
reveal virulence-associated genes. Deletion of the Type III effector
protein ExoU has no statistically significant impact on PA14 virulence in
C. elegans (B and D and [25]). A) Hypothetical protein PA4016 and
adjacent loci PA4017 and PA4015; PA4016 is most likely a single gene
transcription unit. B) A PA4016 MAR2xT7 insertion mutant (#22683) in
the DexoU strain background has attenuated virulence in C. elegans, but
a second PA4016 insertion allele (#41856) in the WT strain does not. C)
Glutathione synthetase, gshB (PA0407), is a single gene transcription
unit. D) Multiple alleles of gshB exhibit reduced virulence in C. elegans
but the gshB #6613 allele in the DexoU strain background is more
attenuated.
doi:10.1371/journal.ppat.1002813.g005
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Locus Description P. aeruginosa host Virulence-attenuated
gacA two-component regulator nematode, mouse[
13]
Vfr cAMP dependent transcriptional regulator mouse (PAK)[
109]
pchH ABC transporter slime mold, fly, mouse (22D10)[
99]
PA4005 conserved hypothetical protein
PA14_27700 putative transcriptional regulator nematode[
32]
pepP proline aminopeptidase
hemK probable translation release factor methyltransferase
lysC aspartokinase
vqsR transcriptional regulator nematode (TB toxin killing)[
108]
kinB two-component sensor zebrafish, mouse (PA01)[
86,103]
ptsP Phosphoenolpyruvate-protein phosphotransferase nematode, mouse[
13]
lasR HSL quorum sensing regulator nematode, mouse[
13,110,111]
PA0745 putative enoyl-CoA hydratase isomerase nematode (PA01 cyanide)[
54]
rhlR HSL quorum sensing regulator nematode[
111]
PA2550 putative acyl-CoA dehydrogenase
Mind cell division inhibitory membrane ATPase F. tularensis[
112]
PA1592 hypothetical protein
glnK nitrogen assimilation signal transduction protein S. typhimurium[
76]
aruD arginine catabolism
gshA glutathione biosynthesis
PA2015 putative isovaleryl-CoA dehydrogenase
PA0456 cold shock domain protein
prpC methylcitrate cycle propionate metabolism nematode (PA01 cyanide)[
54] M. tuberculosis[
113]
gacS two-component sensor kinase nematode, mouse[
13,54]
lasI quorum sensing HSL production mouse (PA01)[
28]
pchI ABC transporter slime mold, fly, mouse[
99]
aruG arginine catabolism
fabF1 fatty acid biosynthesis fly, mouse[
45]
clpA ClpP protease chaperone & ATPase H. pylori[
114]
aruB arginine catabolism
PA1766 conserved hypothetical protein
PA1216 hypothetical protein
pqsE quorum sensing regulation mouse[
115]
kdpD two-component sensor kinase S. typhimurium[
76]
PA1767 hypothetical cytoplasmic membrane protein
prpB methylcitrate cycle propionate metabolism nematode (PA01 cyanide)[
54]
fha2 type VI secretion protein
gshB glutathione biosynthesis
aruC arginine catabolism
wbpL LPS O antigen synthesis nematode, mouse[
32,33]
pilA type IV pilus protein nematode, mouse, human
cells[
32,116,117]
pilF type IV pilus protein nematode, mouse, human
cells[
32,116,117]
ORF_11 LPS O antigen synthesis nematode, mouse[
32,33]
Genes are listed in descending order of contribution to virulence (according to the ratio of mutant LT50/wild-type LT50) using the data from Figure 2. Genes previously
identified as required for normal levels of P. aeruginosa virulence in various model systems are indicated. In some cases only P. aeruginosa strains other than PA14 were
examined and the strain and mode of killing is indicated in parentheses. The other pathogens, in which orthologs of these genes have been implicated in virulence, are
noted in the last column.
doi:10.1371/journal.ppat.1002813.t001
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of multiple virulence factors or virulence associated pathways
[58,59]. Both lasR and rhlR mutants have a spectrum of pigment
and motility defects. lasR and rhlR mutants produce reduced levels
of the blue-green pigment pyocyanin, rhlR produces no pyocyanin,
and lasR mutants produce varying amounts dependent on
conditions and growth phase [60]. Under certain growth
conditions, rhlR and lasR mutants have been reported to produce
less of the fluorescent siderophore pyoverdine [61]. lasR and rhlR
mutants also exhibit dramatically reduced swarming motility [62],
which is dependent on both the type IV pilus and the flagella and
regulated by quorum sensing and a host of transcription factors
[63].
We tested the seven selected virulence-related mutants for
defects in motility (twitching, swimming and swarming assays) as
well as for pyocyanin and pyoverdine production in comparison to
lasR and rhlR mutants to determine whether they had a similar
spectrum of defects and/or could be classified into groups based
on common pigment or motility phenotypes (Table 2). It should be
noted that of these phenotypes, only mutants in which type IV
pilus function is affected have been shown to exhibit reduced
virulence in the C. elegans infection model; pyocyanin does not
appear to be necessary for virulence in the SK model and the roles
of pyoverdine production, swimming and swarming have not been
directly tested [12,14]. Significantly, with the exception of
PA14_27700, all of the mutants exhibited defects in some aspect
of motility or pigment production. Mutation of putative cold shock
protein PA0456 diminished pyocyanin production as did the
quorum sensing regulators lasR and rhlR, whereas a pepP mutant
had elevated pyocyanin levels. The putative enoyl-CoA hydratase/
isomerase PA0745 produced reduced levels of pyoverdine. Among
the tested mutants, 4/7 had clear swarming defects, but exhibited
normal levels of swimming and twitching motility, suggesting that
neither flagella nor type IV pili function was compromised. The
clpA mutant was slightly attenuated for swarming and twitching,
implying that there might be a type IV pilus defect in this mutant.
Characterization of Genomic and Phylogenetic
Distribution of Virulence-Attenuated Genes
The list of PA14 genes identified as being required for full
virulence in C. elegans from the genome-wide screen provided the
opportunity to examine the distribution within a species and
conservation across bacterial species of a large set of genes
required for virulence in a single host. We determined whether this
set of virulence associated genes was biased towards Pseudomonas
core or strain-specific (auxiliary) regions of the P. aeruginosa genome
(as defined by Mathee et al. [41] and/or whether these virulence
genes were preferentially located on genomic islands, as previously
suggested for Pseudomonas virulence factors [39,40]. In addition, we
examined whether the PA14 virulence genes had a narrow
phylogenetic distribution (unique to PA14, P. aeruginosa, Pseudomo-
nas, or closely-related organisms) or were broadly distributed
across prokaryotic phylogeny.
We used four sets of genes identified in our screen and a set of
previously defined PA14 virulence genes downloaded from the
Virulence Factor Database (VFDB) for all analyses. The sets of
unique genes identified in the primary (294), secondary (170) and
tertiary (41) virulence-attenuated screens outlined above and the
auxotrophic genes identified in the primary screen but subse-
quently discarded (76) were used and for simplicity are referred to
below as primary, secondary, tertiary, and auxotroph sets. All
statistical analyses of the virulence genes identified in the C. elegans
screen were done in comparison to the genes represented in the
non-redundant (NR) library, as opposed to the entire PA14
genome, because this was the starting set for the screen. We used
all four sets of genes in our comparisons to gain statistical power
because the final set of 41 verified virulence-related genes was so
small that most analyses did not make statistical cutoffs. In
addition, using sets of genes from subsequent rounds of screening
allowed us to look for enrichment that correlated with the
refinement of the screen. To compare the virulence-related genes
identified in our screen to previously identified P. aeruginosa genes,
we made use of a set of 241 P. aeruginosa strain PA14 virulence
genes downloaded from the Virulence Factor Database (VFDB)
[52].
PA14 virulence-attenuated genes in the P. aeruginosa core
and auxiliary (strain-specific) genome. Among the 5,893
annotated PA14 genes, 5,016 (85%) are core genes in that they are
also present in P. aeruginosa strains PA01, PACS2, PA2192 and
C3719, four P. aeruginosa clinical isolates [41]. The remaining 15%
of the PA14 genes are designated as the auxiliary PA14 genome
because they are genes that are missing in at least one of these five
sequenced P. aeruginosa strains. The auxiliary genome is dispersed
Figure 6. PchH and PchI but not pyochelin are required for
normal virulence of PA14 in C. elegans. A) pchH and pchI encode
putative ABC transporters with potential export functions and are the
two terminal genes in a pyochelin biosynthetic operon [98]. B) Two
MAR2xT7 transposon insertions in pchI and the single available MAR2xT7
allele of pchH are virulence-attenuated. C) Transposon insertion
mutations in either the pyochelin biosynthetic genes pchE and pchF
or the outer membrane transporter fptA, which transports pyochelin
complexed with iron into the cell, have little effect on virulence.
Mutations in pchH and pchI have been previously shown to produce
wild-type levels of pyochelin in culture supernatant [98] and exhibit
attenuated virulence in a neutropenic mouse model [99].
doi:10.1371/journal.ppat.1002813.g006
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containing strain-specific segments bordered by conserved genes.
It should be noted that approximately 66% of the auxiliary
genome is found in species outside of the Pseudomonas genus [41]
and that the designated auxiliary and core genes may change
somewhat over time as more P. aeruginosa genomes are sequenced.
The distribution of the primary, secondary, and tertiary genes in
the core versus auxiliary genome was statistically identical to the
distribution of genes in the NR set. That is, roughly 15% of the
virulence-related genes were part of the auxiliary genome
(Figure 7A, Table S7). By comparison, we performed the same
analysis with the auxotrophic genes and as expected for genes
necessary for fundamental cellular metabolism, this set was
significantly over-represented in the core genome (p-val-
ue=0.009). Therefore, despite the fact that PA14 is much more
virulent than strain PA01 in the C. elegans killing assay [32], our set
of functionally defined PA14 virulence factors show no bias for the
set of genes that is present in PA14 but absent in PAO1, consistent
with our previous preliminary conclusion based on a much smaller
data set [32]. Likewise, the representation of the VFDB genes in
the core and auxiliary genomes was not significantly different from
that of the NR set.
Location of PA14 virulence-attenuated genes on genomic
island versus non-islands. We retrieved a list of predicted
genomic islands of P. aeruginosa strain PA14 from the IslandViewer
website [64] at (http://www.pathogenomics.sfu.ca/islandviewer/
query.php). IslandViewer combines multiple methods of genomic
island prediction. A list of PA14 genes located on the predicted
islands was compiled. However, we noticed that the set of genes
predicted to be on islands by IslandViewer only included 20 of the
143 genes located on the previously defined genomic islands PAPI-
1, PAPI-2 and PAGI-1 [40,65]. Therefore, an additional set of
genes was compiled consisting of the 143 genes located on these
known islands. We determined whether PA14 virulence genes
identified in the C. elegans screen were associated with predicted
genomic islands or with previously defined islands. Among the
PA14 NR mutant set (3.0%; 131) of the genes represented are
located on predicted genomic islands (similar to the 3.6%; 215 in
entire PA14 genome). None of the identified auxotroph genes were
located on predicted genomic islands and only one was located on
a known genomic island. The virulence-related genes identified in
our screen exhibited no bias for incorporation on the genomic
islands predicted by IslandViewer nor on known genomic islands
(PAPI-1, PAPI-2, and PAGI-1); in fact a non-statistically
significant skew towards non-island regions of the genome was
observed for the primary, secondary and tertiary sets in both
comparisons. (Figure 7B,C, Table S7). This is in contrast to the
significant overrepresentation of VFDB genes located in predicted
genomic islands; i.e., 8.3% of total VFDB genes compared to 3.6%
of genes in the genome as a whole (Figure 7B). However, the
VFDB virulence factors were also marginally underrepresented (1
gene, 0.4%, p-value=0.017) on the known islands PAPI-1, PAPI-2
and PAGI-1 (Figure 7C, Table S7). The data above suggest that
the virulence-related genes identified in the C. elegans SK model are
not preferentially located in plastic regions of the P. aeruginosa
genome.
Breadth of phylogenetic distribution of PA14 virulence
genes across prokaryotes. Are the predominant contributors
to P. aeruginosa PA14 virulence in C. elegans genes that are unique to
PA14 or P. aeruginosa or are they common to many bacteria? The
comparisons above suggest that they are not PA14 specific genes,
but to ask the question more generally we used a variation of the
phylostratigraphy approach [66] in which we evaluated the
breadth of the phylogenetic distribution of each PA14 gene by
examining 727 bacterial genomes for orthologs of these genes.
Each gene was designated as belonging to one of seven breadth
categories or phylostrata (0–6) depending on its distribution across
the bacterial kingdom, with ‘‘0’’ representing genes that are only
present in P. aeruginosa PA14, ‘‘1’’ for genes present in other P.
aeruginosa strains but absent outside the species, ‘‘2’’ for genes
occurring in other species in the genus Pseudomonas but absent
outside the genus, and so forth, with the most broadly-distributed
category ‘‘6’’ found in Archaea as well as bacteria (Figure S13; see
Materials and Methods). It should be noted that each ORF is
given a ‘‘breadth of phylogenetic distribution’’ designation based
on the presence of a putative ortholog in the most distantly related
organism and does not necessarily imply that orthologs for the
given ORF are present in all groups less divergent than this most
distantly related organism.
Whereas ‘‘breadth of phylogenetic distribution’’ may be a
meaningful surrogate for the age of a gene in the case of
eukaryotes, there is a significant pitfall to using it as such in
Table 2. Pigment and motility phenotypes of seven novel virulence mutants.
Strain Pyocyanin Pyoverdine Twitching (cm) Swimming (cm) Swarming (SK) Swarming (LB)
lasR (deletion) 0.0660.01 1.1060.18 0.4960.02 2.3060.12 6 2
rhlR (deletion) 0.00 1.1160.17 0.5360.01 2.5360.09 22
PA0456 (#36116) 0.2060.11 1.0760.04 0.5360.02 2.4360.03 + 6
PA0745 (deletion) 1.0560.04 0.3360.04 0.5660.02 2.3260.05 66
pchH (#23790) 0.8960.12 0.9960.04 0.5360.02 2.4060.03 + 6
pchI (#35711) 1.1260.05 1.0960.07 0.6060.01 2.3060.10 + 6
pepP (#31907) 1.4660.13 0.9660.06 0.5860.02 1.9360.03 +++ +++
clpA (#39351) 0.9260.01 0.8860.05 0.4860.02 2.3060.12 + +++
PA14_27700 (#32578) 0.9860.03 0.9260.06 0.5860.02 2.4060.00 +++ +++
PA14 WT 1.00 1.00 0.5960.01 2.3160.02 +++ +++
The average ratio of mutant to wild-type pyocyanin levels from four samples and the SEM is shown. The average ratio of mutant to wild-type pyoverdine levels from
four samples and the SEM is shown. Twitching motility (1.5% LB agar) was measured as the radius of growth at the interface of the medium and the polystyrene plate
and average radius and SEM from three inoculations is presented. Swimming motility was determined by the diameter of the turbid zone in semi-solid LB agar (0.35%)
and average radius and SEM from three inoculations is presented. Swarming levels on the surface of 0.5% agar medium were qualitatively evaluated with number of
and length of tendrils taken into account.
doi:10.1371/journal.ppat.1002813.t002
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prokaryotic lineages could distort the apparent age of a gene. An
apparently young, narrowly distributed gene could be older than it
seems if horizontally transferred from a previously unrelated
unsequenced organism, but it would appear to be a new within the
P. aeruginosa lineage. A more serious problem is presented by genes
that appear older than they are, as a result of a limited number of
horizontal gene transfer events between unrelated lineages. We
reasoned that we could mitigate this latter complication by
including information about the frequency of occurrence across
the clades in which genes are represented. Broadly distributed
genes that occur with high frequency across their phylogenetic
breadths, have, we believe, a greater likelihood of being genuinely
‘‘old’’ genes. We therefore created a subset of our most broadly
distributed genes, categories 4, 5, and 6, that are also represented
in 50% or more of the sequenced genomes in the clades in which
they occur. We dubbed this subset ‘‘high-frequency-broad-
phylogeny’’ or HFBP genes, which comprise 6.9% of the NR
Set. Since we were also interested in examining the representation
of the newest or most recently acquired genes in P. aeruginosa strain
PA14, we also considered genes that were Pseudomonas-genus-
specific, which we dubbed ‘‘PGS’’ genes. For this set, we binned
genes of breadths 0, 1, and 2, which total 9.6% of the NR set,
reasoning that such a set would represent relatively new genes,
while at the same time being a large enough set to provide some
statistical power.
The distribution of phylogenetic breadths of all the PA14 genes,
all the PA14 NR set mutants, and the primary, secondary, tertiary
and auxotrophic set mutants is shown in Figure S13, with
statistical analysis presented in Table S7. The virulence-attenuated
primary, secondary, and tertiary sets of genes identified in the C.
elegans screen show a trend of underrepresentation in the narrowest
phylogenetic breadth classes, with the tertiary positives, the set that
predominantly includes highly virulence-attenuated mutants,
being most underrepresented in the narrow phylogenetic breadth
classes. However, taken individually, these underrepresentations
are not statistically significant, due to the small number of mutants
in each set.
When the same analysis was performed examining the HFBP
and PGS gene sets in comparison with all the other PA14 genes
(Figure 8, Table S7), we observed that there was a significant
overrepresentation of HFBP genes among auxotroph set (p-
value=5.47610
228) and in the primary, secondary and tertiary
mutant sets (p-values of 0.00004, 0.0005, 0.006, respectively). At
the same time, there was an underrepresentation of Pseudomonas-
genus-specific (PGS) genes among the primary set (5.8% vs 9.6%
in the NR Set, with p-value=0.01), and the proportion of PGS
genes appeared even more depleted among secondary and tertiary
gene sets (5.3% and 2.4%), although the smaller size of these sets
rendered these underrepresentations not statistically significant.
However, we believe the statistically significant underrepresenta-
tion of PGS genes in the primary set, combined with the
successive, increasing depletion of that category in the secondary
and tertiary positives, suggests that those depletions are not
spurious. In contrast to the gene sets from our screen, HFBP genes
were underrepresented in the VFDB P. aeruginosa strain PA14 gene
set (p-value=0.00013). The apparent underrepresentation of
Pseudomonas-genus-specific genes, most likely the youngest genes,
and the overrepresentation of high-frequency-broad-phylogeny
genes that likely represent older genes, point to a skew in the
primary, secondary, and tertiary mutant sets toward older genes,
and away from young, newly-acquired, or fast-evolving genes.
Taken together, these analyses of the genomic and phylogenetic
distribution of virulence-attenuated genes demonstrate that the
Figure 7. The distribution of P. aeruginosa PA14 genes required
for virulence in C. elegans in the Core vs. Auxiliary genome and
on both predicted and known genomic islands. A) The
percentages of P. aeruginosa PA14 genomic genes, PA14-NR Set
mutants, and primary, secondary, tertiary, auxotroph, and VFDB set
genes that are part of the P. aeruginosa core and auxiliary genome as
defined by Mathee et al. [41]. The auxotroph set is disproportionately
part of the core genome. Genes in the primary, secondary, tertiary, and
VFDB sets have proportions in the core and auxiliary genes that are
statistically indistinguishable from the PA14 NR set and from the
genome as a whole. B) The percentages of genes from the PA14
genome, the PA14-NR Set, and from the primary, secondary, tertiary,
auxotroph, and VFDB sets that are located on genomic islands
predicted by IslandViewer. Representation of primary, secondary, and
tertiary gene sets on predicted islands was statistically representative of
the genome as a whole and of the NR-set, whereas VFDB genes had a
statistical overrepresentation of genes located on predicted genomic
islands (p=0.0005). C) The percentages of genes from the PA14
genomic, the PA14-NR Set, and from the primary, secondary, tertiary,
auxotroph, and VFDB sets located on the known PAPI-1, PAPI-2, and
PAGI-1 genomic islands. Representation of primary, secondary, and
tertiary set genes was statistically identical to the genome as a whole
and the NR-set. VFDB genes were statistically underrepresented on the
known islands (p=0.007). Refer to Table S7 for statistics.
doi:10.1371/journal.ppat.1002813.g007
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throughout the PA14 genome on both predicted genomic island
and non-island regions, are not unique to a particular P. aeruginosa
strain and in fact are disproportionately potentially old genes with
identifiable orthologs across a wide breadth of prokaryotic species.
Discussion
P. aeruginosa PA14 Genes Required for C. elegans Killing
We set out to define the spectrum of genes required for P.
aeruginosa PA14 infection in a single host organism with the
ultimate goal of elucidating the mechanisms underlying patho-
genesis in this multi-host opportunistic pathogen. A genome-wide
unbiased screen for P. aeruginosa strain PA14 mutants defective in
killing C. elegans identified a set of 180 putative virulence-related
mutants (corresponding to 170 genes) after two rounds of
screening. The screen was validated by the isolation of mutants
previously shown to be required for P. aeruginosa virulence in both
nematodes and mammals or known to regulate processes or
pathways linked to pathogenesis including, but not limited to,
genes involved in quorum sensing, two component regulators of
virulence, transcriptional regulators, genes involved in type IV
pilus production, and O-antigen biosynthesis. Twenty genes in the
170 gene set overlapped with a set of previously defined virulence
factors in VFDB, a database of Pseudomonas-related virulence
factors. Overall, the PA14 genes identified in the genome-wide
screen have an overrepresentation of highly conserved genes
present in many bacterial phyla and are part of the stable P.
aeruginosa genome, rather than being located on pathogenicity
islands.
The set of 170 virulence-related genes is broadly distributed
across 27 defined functional classes and DAVID GO term analysis
and mapping onto KEGG pathways did not reveal any
interpretable enrichment for particular functions or pathways.
This breadth of functional classes parallels the virulence-attenu-
ated mutants identified in an independent unbiased screen using
signature tagged mutagenesis carried out by Potvin and coworkers
in a rat chronic infection model [46]. Unlike the genes identified in
our screen and by Potvin et al., virulence-related factors in the
VFDB are enriched for secretion- and adherence-related proteins.
A major difference between the virulence-related genes in VFDB
and the genes identified in our unbiased screen is that many of the
genes in VFDB were included because they encode secreted
toxins, secretion systems, or cell surface structures [52,67].
However, the sensitivity of our screen favored identification of
mutants with strongly attenuated virulence. This was expected
given the nature of the primary screen that required that both the
parent nematodes live long enough to produce a significant brood
and that the nematode brood mature on the mutant bacterial
lawn. It is possible, therefore that mutants with a weak virulence-
attenuated phenotype were not detected and this could potentially
skew the collective analysis of virulence factors.
One explanation for why so few mutants identified in our screen
correspond to secretion pathways or to secreted effectors is that
many of P. aeruginosa virulence effectors appear to function
redundantly in the C. elegans killing assay. In support of this
conclusion, disruption of the ExoU cytotoxic phospholipase had
no statistically significant impact on virulence, but appeared to
create a sensitized background that allowed the detection of other
relatively weak virulence factors. Further, McEwan et al. have
shown that whereas PA14 exotoxin A (toxA) mutants have no or
little defect in virulence, overexpression of ToxA in E. coli activates
the worm immune system and ultimately kills an immune-
compromised animal, suggesting that ToxA may play an active,
but to date undetected, role in PA14 pathogenesis in the nematode
host [68]. Similarly, Dunbar et al. [69] have shown that ToxA
inhibits protein synthesis in C. elegans intestinal cells during an
infection. ExoU and ToxA are secreted by distinct systems and the
weak virulence attenuation of secretion system mutants in C. elegans
implies that multiple secretion systems and effectors may
contribute to virulence in C. elegans with no single system being
paramount.
An alternative explanation for the identification of a limited
number of secretion-related mutants in our screen may be linked
to the fitness costs of maintaining a large set of effectors targeting a
wide range of potential hosts. Only four Type III effectors have
been identified in P. aeruginosa, whereas 46 families of effector
proteins have been identified in various strains of the related plant
pathogen P. syringae [70] and a typical P. syringae strain has 20 to 30
effectors [71]. In P. syringae, which has a much more limited host
Figure 8. Among the PA14 genes required for virulence in C.
elegans,‘ ‘ Pseudomonas-genus-specific’’ (PGS) genes are under-
represented, whereas ‘‘high-frequency-broad-phylogeny’’
(HFBP) genes are overrepresented. Based on phylostratigraphic
analysis, PA14 genes required for virulence in C. elegans were classified
as either ‘‘Pseudomonas-genus-specific’’ (PGS), presumably representing
the newest genes in PA14, ‘‘high-frequency-broad-phylogeny’’ (HFBP),
representing the oldest, most conserved genes in PA14, or ‘‘all others’’.
The percentage of each gene set, including the PA14 genome genes,
the PA14-NR, primary, secondary, tertiary, auxotroph, and VFDB gene
sets that are classified as PGS genes, HFBP genes, or all others genes,
are shown. HFBP genes comprise 10% of the PA14 genome, and about
7% of the NR set genes. Furthermore, HFBP genes are increasingly
overrepresented with successive iterations of the screen accounting for
13% of the primary set (p-value=0.00004), 14% of the secondary set (p-
value=0.0005) and 19% of the tertiary set (p-value=0.006). HFBP genes
make up greater than 50% of the auxotroph set with a (p-
value=5.47610
228) relative to the NR set. The PA14 VFDB set contains
an underrepresentation of HFBP genes (1.6%, p-value=0.0001). PGS
genes make up 11% and 9.6% of the PA14 genome and NR set
respectively. Over successive iterations of the screen, PGS genes
become numerically more underrepresented relative to the NR set,
comprising 5.7% of the primary set (5.7%, p-value=0.01), 5.2% of the
secondary set (p-value=0.03, not statistically significant), and 2.4% of
the tertiary set (p-value=0.08, not statistically significant). Due to the
small numbers of genes in the secondary and tertiary sets, only the
underrepresentation in the primary set is significant after application of
multiple comparison correction (FDR, q,=0.05). PGS genes are
underrepresented in the auxotroph set (0%, p-value=0.0006). Statistical
data for this figure are presented in supplemental Table S7.
doi:10.1371/journal.ppat.1002813.g008
Screen for P. aeruginosa Virulence in C. elegans
PLoS Pathogens | www.plospathogens.org 13 July 2012 | Volume 8 | Issue 7 | e1002813range than P. aeruginosa, type III effectors mostly target host
defense signaling pathways and both enhance virulence in
particular host plants, while eliciting a strong immune response
in others [72]. This fact, combined with the observations that the
genes encoding secreted effectors are often under diversifying
selection [38,73] and are typically located in plastic regions of the
genome [70,74], suggests that P. syringae strains actively co-evolve
with a limited number of hosts. In contrast, from first principles, it
seems highly unlikely that a broad host-range pathogen like P.
aeruginosa PA14 can be simultaneously co-evolving with all of its
multiple hosts. Therefore P. aeruginosa might employ a broader set
of strategies to ensure survival in diverse hosts instead of
maintaining large sets of host-specific virulence-related effectors.
In this context, a number of the strongly virulence-attenuated
PA14 mutants identified in our screen may correspond to factors
that enable survival of P. aeruginosa in the hostile environment of
the C. elegans intestinal tract, which is acidic and filled with
enzymes such as proteases, lipases, and DNAse that potentially
disrupt bacteria [75]. Moreover, in response to pathogens, the
nematode specifically upregulates transcription of many putative
antimicrobial genes [18]. In order for P. aeruginosa to proliferate in
the intestine and cause disease, it first has to survive. Both the two
component potassium sensor KpdD and the nitrogen assimilation
regulatory protein GlnK, identified in our screen, have recently
been shown to play a role in the persistence of S. typhimurium in the
C. elegans intestine and defects in outer membrane integrity may
reduce the survival of kdpD and glnK mutants in the host [76]. In
addition, the identification of two PA14 genes required for
biosynthesis of glutathione, gshA and gshB, may be related to the
role of glutathione as a protectant against stresses encountered in
the worm intestine including reactive oxygen species and low pH
[77]. Cold shock domain proteins, like PA0465 identified in our
screen are another class of molecule that are induced by
environmental stress and are generally thought to play a protective
role in the cell [78].
Identification of a number of PA14 mutants corresponding to
metabolic genes illustrates the importance of nutrient acquisition
in virulence. Without specific biosynthetic or metabolic capabilities
a pathogen may be unable to colonize or grow within a host. For
example, P. aeruginosa mutants defective in purine biosynthesis are
unable to replicate in neutropenic mice, presumably because the in
vivo environment is deficient in purine [48]. In the cases of
intercellular pathogens such as Listeria monocytogenes and Mycobac-
terium tuberculosis, specific amino acid and nucleotide auxotrophs
are reduced in growth in vivo [79,80]. We identified a number of
metabolic genes including prpB and prpC and several aru genes that
may be important for bacterial metabolism and growth under the
nutrient conditions within the nematode intestine. Further, some
of the putative virulence-attenuated mutants identified in the
primary screen that were set aside for further study because they
were determined to be auxotrophs (a typical step in many screens)
might specifically reflect nutrient availability in the nematode
intestine. In this regard it is notable that mutations in nine purine,
five pyrimidine, and six tryptophan biosynthetic genes were
identified in the primary screen for virulence-attenuated mutants,
and although some of these mutants exhibited reduced growth on
the killing assay medium, many did not have any observable
difference from wild-type PA14, suggesting that the reduction in
virulence might be due to aberrant growth of these auxotrophs in
vivo.
The predominant contributors to PA14 virulence in our C.
elegans infection based assay appear not to be individual effectors,
but genes that regulate numerous effectors (like the quorum
sensing regulators lasR and rhlR), genes that are vital for protecting
the bacteria from the host defense onslaught, and genes that help
P. aeruginosa obtain the necessary nutrients to survive in the host.
Therefore the strategy of a broad host range opportunistic
pathogen might fundamentally differ from a pathogen that targets
specific hosts, relying more on multiple partially redundant
secretion systems and their cognate effectors and strategies for
survival under a wide-variety of metabolic and environmental
conditions.
Location of P. aeruginosa Virulence Factors in the Core P.
aeruginosa Genome
The long-recognized association between virulence genes and
regions of genomic plasticity, particularly genomic islands
acquired by lateral transfer of genetic material [81], has been
attributed to the competitive advantage conferred by horizontally-
acquired virulence factors in an ongoing co-evolutionary struggle
between a host and pathogen. Two pathogenicity islands carrying
plant and animal virulence-related genes have been identified and
characterized in P. aeruginosa PA14 (PAPI-1 and PAPI-2). Of the 11
genes located on PAPI-1 previously shown to be required for
normal levels of virulence in plants and mice [40], only one (rcsC)
was identified in our secondary screen as a weak mutant and it did
not re-test in the tertiary screen. Overall our results showed no
enrichment of virulence-associated genes on predicted genomic
islands, or on the known genomic islands PAPI-1, PAPI-2, or
PAGI-1. More generally, whether or not virulence genes in
aggregate are preponderantly associated with genomic islands in P.
aeruginosa has not been experimentally demonstrated. The statis-
tical power of analysis with respect to the genomic locations of
genes is limited in part by the fact that not all genes are expected to
segregate independently. In this regard, it is worth noting that the
apparent enrichment of P. aeruginosa VFDB genes on predicted
genomic islands is primarily due to the cluster of functionally
interdependent Type III secretion apparatus genes located
between gene loci PA14_42440 and PA14_42660. In summary,
our data and analysis of existing data suggest that neither P.
aeruginosa VFDB genes nor the virulence-attenuated genes identi-
fied in our screen are preferentially found on genomic islands.
Roughly paralleling our observations with genomic islands, our
analysis of the frequency of PA14 virulence genes in the core and
auxiliary genomes (both from our screen and the VFDB) showed
no statistically significant over or underrepresentation. The main
difference between the core versus auxiliary genome distinction,
and that of genomic islands, is that auxiliary genes include both
genes that are lost from the genomes of some isolates, as well as
those genes that are newly acquired. Genomic islands by contrast,
specifically include only newly acquired genes. Taken together,
these results suggest that there is no specific enrichment of P.
aeruginosa virulence-related genes on islands or in strain-specific
regions of the P. aeruginosa genome, at least with respect to those
that are involved in the C. elegans slow killing assay.
To further test the hypothesis that the arsenal of P. aeruginosa
virulence factors includes newly evolved and or newly acquired
genes we investigated the phylogenetic breadth of distribution of
the PA14 virulence genes, as well as the degree to which they
belong to a set of putative old conserved genes, the so-called high-
frequency-broad-phylogeny (HFBP) set, and probable newer
genes, the Pseudomonas-genus-specific (PGS) set. We found that
consistent with the result that virulence genes are not located on
islands, that PA14 virulence genes involved in C. elegans killing are
enriched in HFBP genes, which as a group are likely to be the most
ancient and conserved prokaryotic genes. The vast majority of
PA14 virulence genes appear not to be specific to the Pseudomonas
genus, and in fact, such recently acquired or novel genes are
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observations underscore the point that many virulence factors with
the most significant contribution to virulence can be old, highly
conserved genes.
Assessing the Generality of the P. aeruginosa C. elegans
Infection Model
Although the C. elegans model, in which nematodes are ‘‘force-
fed’’ a monoculture of P. aeruginosa [13,43,44], is somewhat
artificial, so are other laboratory models of P. aeruginosa infection
that require pricking of the body of a fly [45], lung inoculation
with agarose beads in rats [46] and mice [47], and non-lethal
cutaneous burns in mice [82]. The artificiality of these models and
the need for a compromised host is in part dictated by the
opportunistic nature of the pathogen. The fact that conserved
immune defense pathways are activated in the C. elegans host by P.
aeruginosa strongly supports the view that the nematode is
responding to P. aeruginosa as a pathogen [83]. Although we don’t
yet know whether P. aeruginosa is a natural pathogen of C. elegans,
since both organisms live in the soil, it is likely that they encounter
one another, and it is not inconceivable that the pathogenicity
interactions that we observe may approximate the interactions of
P. aeruginosa with weakened individual C. elegans animals in the wild.
Although some putative P. aeruginosa virulence factors are
common to both mammalian and C. elegans host models, the
degree to which P. aeruginosa virulence factors are shared, and
implicitly, the degree to which P. aeruginosa virulence strategies are
common to C. elegans and mammalian hosts is not yet clear. That
only a single putative virulence-related gene is shared between the
170 virulence-attenuated genes from our secondary set, the rat
chronic infection set defined by Potvin et al., and the VFDB set,
argues against the idea of a core set of virulence factors common to
all infection models. The spectrum of virulence factors that play a
role in a given host model is likely to depend on a wide variety of
factors including the characteristics of the site of infection, such as
pH, ionic strength, nutrient availability, and temperature, the type
of immune compromise, the phase of infection, and the particulars
of the immune response, including the presence of host factors,
and even host behavior. Indeed, two additional PA14 pathoge-
nicity assays in C. elegans have been developed in our laboratory, a
toxin-mediated killing model [12,14] and a liquid killing assay (N.
Kirienko and F. Ausubel, unpublished). PA14 appears to utilize
distinct mostly non-overlapping sets of virulence-related genes to
kill nematodes in the three different models. Nevertheless, all three
of these assays have identified virulence factors that play important
roles in various aspects of mammalian pathogenesis. The
implication for human pathology is that the predominant
virulence factors that play a role in different types of P. aeruginosa
infection in humans may be somewhat distinct.
Implications for Multi-host Opportunistic Pathogens
In summary, the data from our unbiased genome-wide screen
for P. aeruginosa virulence factors involved in C. elegans killing in a
specific infection model, suggest that in comparison to host-specific
pathogens, P. aeruginosa may employ a smaller arsenal of host-
specific effectors, and rely more on conserved, generic virulence
factors and on its ability to endure host defense responses. While it
is not yet clear that this same strategy is employed by multi-host
pathogens beyond P. aeruginosa that are capable of infecting
organisms from multiple phylogenetic kingdoms, this may explain
why the major genes contributing to PA14 virulence in C. elegans
are not overrepresented on genomic islands, are not PA14 or P.
aeruginosa specific genes, and may in fact be biased for ancient
genes common to many other prokaryotic species. These
observations are consistent with the view of P. aeruginosa PA14 as
a generalist pathogen for which the relationship with C. elegans is
opportunistic rather than co-evolved. Indeed it is likely that no
significant co-evolution occurs between P. aeruginosa and any of the
hosts for which it is an opportunistic pathogen, both because of the
rarity of pathogenic interaction, and because of the likelihood that
co-evolution with multiple hosts would necessitate balancing
opposing evolutionary pressures from those hosts. From a clinical
perspective, the multiplicity and apparent combinatorial nature of
P. aeruginosa’s virulence factors may pose a challenge for the
development of new therapeutics to fight Pseudomonas infection.
This work does not settle the question of whether the profile of
virulence factors of a multi-host pathogen is likely to be different
from that of host-specific pathogens in terms of the reliance on
conserved effectors that target highly conserved features of
eukaryotic biology, but it is a question that deserves further
inquiry.
Materials and Methods
Bacterial Strains
P. aeruginosa strain PA14 mutants are gentamycin resistant
MAR2xT7 transposon insertion mutants unless otherwise stated
[42]. The lasR mutant used as a control was a deletion that
removes the lasR ATG and carries a gentamycin cassette [84].
Similarly, the rhlR mutant used as a control in the pigment and
motility assays was a deletion mutant that carries a gentamycin
cassette [84]. These mutants have an identical avirulent phenotype
to subsequently generated clean in-frame PA14 DlasR and DrhlR
mutants (data not shown). The pilA mutant is a tetracycline
resistant Tn5-B30 transposon insertion mutant provided by G.
O’Toole [85]. DPA0745 is a complete in-frame deletion of the
ORF with a concomitant insertion of a PacI restriction site
generated by the method previously described in Chand et. al.
[86]. Unless otherwise indicated, MAR2xT7 mutant bacteria were
streaked from frozen stocks onto LB agar containing 15 mg/ml
gentamycin to isolate single colonies used for inoculation. WT
PA14 (as well as lasR and pilA mutants) was streaked on LB agar
containing 100 mg/ml rifampicin.
Nematode Strains
N2 Bristol L4 animals were used for the primary and secondary
screens. Tertiary tests were done with CF512 fer-15(b26)II;fem-
1(hc17)IV temperature sensitive sterile nematodes. CF512 worms
were propagated at 15uC, egg-prepped and hatched overnight at
20uC in M9 liquid media in the absence of food. Starved L1
animals were dropped onto NGM plates seeded with standard E.
coli OP50 and grown for approximately 20 hours at 15uC and then
20 more hours at 25uC to generate staged L4 sterile animals for
experimentation.
Primary Screen
We used the non-redundant PA14 MAR2xT7 transposon library
of ordered mutants to screen for avirulent mutants [42]. The entire
library was screened twice with the exception of a single 96-well
plate of mutants (plate 14.3) that was not screened because it
contained mostly known slow-growing mutants. Bacteria were
inoculated from the frozen 96-well stock plates into 150 mlo fL Bi n
0.5 ml 96-well Masterblocks (Greiner) and grown overnight with
shaking for 16 hours at 37uC. 10 ml of each culture was spotted
onto slow killing (SK) agar (standard nematode growth media,
NGM, containing 0.35% instead of 0.25% peptone) in each of two
wells of a 6-well culture plate (Falcon) [12]. Two previously
identified virulence-attenuated mutants, quorum sensing regulator
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attenuated) were included as positive controls in the screen. Plates
were scored qualitatively after 4 days at 25uC and designated as
either ‘‘strong’’, indicating large numbers of gravid animals
(generally on lasR mutant bacteria hundreds of gravid nematodes
were present and the bacterial lawn was mostly or completely
consumed) or ‘‘weak’’, indicating an observable increase in the
number of worms or gravid adults present compared to PA14 (pilA
usually resulted in an increase in the total brood size with a bias
towards older stage larvae and gravid adults; the pilA control wells
exhibited variability in the number of progeny alive and were near
the limit of sensitivity in the screen). Each mutant was screened
blind on two separate days for a total of four wells screened per
mutant. Mutants that were scored as strong in either one or both
repetitions or weak in both were retained for a total of 399 primary
mutants. Approximately half way through the primary screen it
became clear that lawn growth phenotype was relevant to our
study, and from then on we scored for lawn growth. We therefore
have a crude assessment of growth for about 50% of the mutants
identified in the primary screen.
Auxotroph Screen
All 399 of the mutants from the primary screen were streaked
from the frozen library stock onto LB agar plates containing
15 mg/ml gentamycin and grown overnight at 37uC. To quickly
test for potential auxotrophs, a single colony from each mutant
was picked and streaked on 1) Neidhardt supplemented MOPS
defined media without amino acids or nucleotides (TEKNOVA
EZ Rich Media), 2) Neidhardt supplemented MOPS defined
media plus amino acids and nucleotides, and 3) LB containing
15 mg/ml gentamycin agar plates. Plates were incubated overnight
at 37uC. 86 mutants that either exhibited no growth on minimal
media minus supplements or significantly reduced growth were
removed from the pool of putative avirulent mutants and not
examined in further rounds of screening (Table S2). 15/56 of the
auxotroph mutants for which a plate growth phenotype had been
annotated (see above) had obvious growth defects on SK agar
plates.
Secondary Screen
The 313 mutants from the primary set that exhibited normal
growth on minimal media without addition of amino acids and
nucleotides (Table S3) were screened for attenuation of virulence
in standard SK assays and scored for both killing of parental (P0)
animals and the number and maturity of worm progeny produced
[13]. A single bacterial colony was inoculated into 5 ml of LB
media and grown for 14.5 hours at 37uC with aeration on a
rotating wheel. 10 ml of this overnight culture was spread onto
each of two SK agar plates (3.5 cm culture plates (Falcon), plates
were incubated for 24 hours at 37uC, and then 24 hours at 25uC.
30–40 N2 L4 animals (raised on standard NGM plates with E. coli
OP50 as food) were picked to each SK plate and the plates were
incubated at 25uC for a total of 60–80 animals per assay. Live and
dead animals were counted 2–3 times over 1–3 days after transfer
to the pathogen. Animals were considered dead if they did not
respond to a gentle touch and were removed from the plate. After
4 days at 25uC, the number and age of the nematode progeny on
each plate was qualitatively assessed as compared to those on
PA14 WT. Secondary positives were ranked as ‘‘strong’’ (strongly
virulence-attenuated similar to the lasR mutant), ‘‘moderate’’ (less
attenuated than lasR but greater than or equal to pilA) and ‘‘weak’’
(less attenuated than pilA for parental killing but clearly exhibiting
an increase in progeny number and age over WT PA14). 180
MAR2xT7 mutants exhibited either attenuation of P0 parental
killing or allowed increased production and development of
nematode progeny (Table S4). The identity of the MAR2xT7
mutants was confirmed by sequencing of arbitrary PCR products
as previously described [42], see Table S4.
Tertiary Screen
58 MAR2xT7 mutants were re-screened in standard SK assays
using sterile fer-15(b26)I:fem-1(hc17)IV animals (Table S5). Bacteria
were grown as indicated above for the secondary screen. Three
3.5 cm SK agar plates were seeded with each bacterial strain and
35–50 L4 worms were transferred to each plate for a total of 100–
150 animals per assay. Live and dead animals were counted every
day over approximately 7 days. PA14 WT and lasR were included
in each assay as controls. The resulting 41 virulence-attenuated
mutants shown in Figure 2 were all tested in at least two separate
experiments unless otherwise indicated. Statistical analysis of the
curves summarized in Figure 2 was done using Prism 5 Log-rank
(Mantel-Cox) test and the difference between the mutant and wild-
type curves was highly significant in all cases with a p-
value,0.0001. Time to 50% survival was calculated (Prism 5.0
linear regression Hill equation LogEC50). All killing assays
presented in the manuscript (Figures 3, 4, 5, 6, S5, S6, S7, S8,
S9, S10, and S11) are a representative example of two or more
experiments that resulted in the summary shown in Figure 2.
Assessment of Growth
Growth of bacterial mutants was evaluated by four methods: 1)
Overnight cultures inoculated from a single colony into 5 ml of LB
and grown for 14.5 hours at 37uC with shaking were visually
compared to wild-type PA14 grown under the same conditions.
Mutants that were observably less turbid were considered slow
growers (in the case of PA14_45650 mutant #54246 the cells
appeared to be lysed). 2) Slow killing agar plates spread with each
mutant were examined prior to transfer of worms. Bacterial lawns
that were thin or exhibited other aberrant phenotypes (nusA
mutant #55834 had large colonies that emerged on top of the
lawn) were removed from the mutant pool. 3) Many of the
secondary and tertiary positive mutants were grown overnight in
LB and M63 minimal media in a 96-well plate without shaking
and the OD600 was measured every 15 minutes for 15 hours at
37uC in a Molecular Devices Spectra Max M5. The rate of growth
during two hours of maximal growth was compared to WT (Table
S5). 4) The growth of nine mutants (pchH, pchI, PA14_27700,
PA2550, PA0456, PA0745, clpA, PA1216, vqsR) in 5 ml of M63
minimal in a standard culture tube on a rotation wheel at 37uC
was measured by counting colony forming units. All nine of these
mutants grew as well as WT (Figure S12).
Pyocyanin Assay
A pyocyanin assay was modified from Essar et. al. 1990 [87]. A
single colony of WT or mutant bacteria was inoculated into 5 ml
of LB media and grown for 16 hours at 37uC on a rotating wheel.
1 ml of saturated overnight culture was transferred to a microfuge
tube and cells were pelleted by centrifugation at 14,000 RPM for
2 minutes. 800 ml of the supernatant was transferred to a new
tube, extracted with 600 ml of chloroform and the phases were
separated by centrifugation for 5 minutes at 14,000 RPM. The
chloroform phase was then re-extracted with 0.3 ml of 0.2 N
hydrochloric acid. The pyocyanin content of 100 ml of the aqueous
acidic phase was quantitated based on absorbance at 520 nm. The
A520 was normalized to cell number (A600 of the original overnight
culture). A DphzA1-G1/DphzA2-G2 [88] mutant that does not
produce any phenazines had no detectable A520. The pyocyanin
produced by each bacterial strain was measured from the growth
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four cultures, the ratio of A520 (normalized to cell number as
measured by A600) of mutant to WT was calculated and the
average of these four ratios is shown in Table 2. The error
presented is the SEM of the four mutant/WT ratios.
Pyoverdine Assay
A single colony of WT or mutant bacteria was inoculated into
5 ml of M9 media and grown overnight for 18 hours at 37uCo na
rotating wheel. Cells were pelleted by centrifugation at 14,000
RPM for 2 minutes in a microfuge tube and the supernatant was
diluted 10 fold in 10 mM Tris pH 7.4. Pyoverdine content was
determined by measurement of fluorescence (400 nm excitation,
460 nm emission) [89,90]. No fluorescence above background was
detected in pyoverdine biosynthetic mutants, pvdD (#40342) and
pvdA (#30448). The pyoverdine produced by each bacterial strain
was measured from the outgrowth of two individual colonies on
two separate days. For each of the four cultures, the ratio of
fluorescence (normalized to cell number as measured by A600)o f
mutant to WT was calculated and the average of these four ratios
is shown in Table 2. The error presented is the SEM of the four
mutant/WT ratios.
Swarming Assay
The swarming assay was modified from Overhage (2008) [91].
A single colony of WT or mutant bacteria was inoculated into
5 ml of LB media and grown for 15 hours at 37uC with aeration.
2 ml of each overnight culture was spotted onto the surface of LB
0.5% agar and SK 0.5% agar plates and then incubated at 37uC
overnight. Each mutant was tested in triplicate on two separate
days. As expected, the rhlR mutant (deficient in rhamnolipid
production) and pilA mutant (typeIV pilin) were defective in
swarming [62]. Mutants were visually compared to WT PA14 and
were qualitatively evaluated for swarming radius and number of
tendrils (Table 2).
Swimming Motility
The swimming motility assay was based on Darzins (1993) [92].
A single bacterial colony was picked with a straight end loop and
inoculated into LB swim agar (0.35% agar). Plates were incubated
8–12 hours at 37uC. The diameter of the flagellum-mediated
motility generated turbid zone was measured. Each mutant was
tested in triplicate and the average with SEM is presented in
Table 2.
Twitching Motility Assay
The twitching motility assay was based on O’Toole 1998 [85].
A portion of a single bacterial colony was picked with a straight
end inoculation loop and stabbed to the bottom of a LB agar plate
(1.5% agar). Plates were incubated overnight at 37uC and then 2
days at room temperature. The growth at the interface between
the agar and the polystyrene plate (radius from the inoculation
point) was measured. The pilA mutant exhibited no twitching
motility. Each mutant was tested in triplicate and the average with
SEM is presented in Table 2.
Breadth of Phylogenetic Distribution of P. aeruginosa
strain PA14 Genes Using a Variation of the Method of
Phylostratigraphy [66]
A database of orthologs of P. aeruginosa strain PA14 genes across
727 sequenced prokaryotic genomes (including PA14) was created.
Finished microbial genome sequences were obtained as down-
loaded packages from the NCBI ftp site (ftp://ftp.ncbi.nlm.nih.
gov/genomes/Bacteria/) on August 25, 2008. PA14 proteins were
used as BLASTP queries against each bacterial genome. Putative
orthologs were reciprocal best hits against the corresponding
proteins in the subject genomes. Blast results against subject
genomes were required to have an e-value equal to or less than
0.0001. Reciprocal blasts against the PA14 genome were required
to have e-values of 0.001 or less. Putative orthologs were required
to align for at least 80 percent of their length and have less than
20% difference in protein sequence lengths, thereby conserving
overall domain structure. The e-value constraint was permissive to
allow detection of distant orthologs, but the requirement for
alignment length was fairly stringent. Breadth of phylogenetic
distribution, also called phylostratum, was a measure of the
maximal phylogenetic distance at which an ortholog occurs.
Breadth was defined as: 0 for proteins specific to PA14, 1 for
proteins that occur in multiple strains of Pseudomonas aeruginosa, but
not in other species, 2 for proteins that occur in multiple
Pseudomonas species but not in other genera, 3 if across gamma
and beta proteobacteria, 4 if across proteobacteria, 5 if across
eubacteria, and 6 if across eubacteria and archaea (Figure S13).
Statistics
P-values for overrepresentation and underrepresentation were
calculated as Fisher Exact Test right and left probabilities,
respectively, using version 1.21 of the Text::NSP::Measures::2D::-
Fisher Perl module, available from CPAN.org [93]. Multiple
comparison correction using False Discovery Rate (FDR) was
performed where indicated [94]. The maximal value of q was
0.05.
KEGG Pathway and GO Term Analysis
Genes of P. aeruginosa strain PA14 were mapped to KEGG
pathways using the KEGG Mapper program (http://www.
genome.jp/kegg/tool/map_pathway1.html). The total number
of mutants in each pathway was summed for those genes in the
PA14 NR set and for each mutant set analyzed. P-values for
overrepresentation of each pathway were calculated using Fisher
exact test right-probabilities, and their significance was assessed
using the Bonferroni correction [94,95]. GO term analysis was
performed using DAVID (http://david.abcc.ncifcrf.gov/home.jsp)
using the genes in the NR set as a background, and the genes in
the sets of analyzed positives as gene-lists. The DAVID software
package calculates p-values for each GO term automatically, and
also gives an EASE score, which was used to assess the significance
of the overrepresentation of any given GO term.
Supporting Information
Figure S1 Flow chart of screening procedure for
virulence-attenuated PA14 transposon mutants in C.
elegans.
(TIF)
Figure S2 Correlation of virulence attenuation in stan-
dard SK and progeny survival assays. A) lasR, gacA, ptsP,
mucD, rhlR and pilA mutants all have attenuated virulence in a
standard slow killing (SK) assay (60–80 N2 worms tested). B) The
number and developmental stage of the progeny on the SK plates
in panel (A) four days after transfer of the parent worms to
pathogen at 25uC. On PA14, there were few progeny and no
gravid adults were observed whereas gravid adult progeny were
found on the virulence-attenuated P. aeruginosa strains. The
number and age of progeny on the mutant plates was qualitatively
scored in comparison to the PA14 WT plates. Plates seeded with
gacA and ptsP were overrun with hundreds of gravid adult worms
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contained fewer gravid adult worms but all were observably
greater than plates seeded with WT PA14.
(TIF)
Figure S3 Percentage of mutants that are VFDB genes.
The percentage of primary, secondary, and tertiary, and
auxotroph set virulence-attenuated genes that are VFDB and
non-VFDB genes are indicated. VFDB genes are significantly
overrepresented in the primary, secondary, and tertiary sets, with
p-values of 5.5610
26, 2.1610
25, and 3.7610
25, respectively.
Furthermore, their overrepresentation increases with successive
screen iterations.
(TIF)
Figure S4 Venn diagram showing the overlaps between
the 170 virulence-attenuated genes obtained in the
secondary screen, the Potvin set, and the PA14 VFDB
set.
(TIF)
Figure S5 Multiple pepP alleles but not alleles of other
genes in the operon have attenuated virulence. A) PepP is
a cytoplasmic aminopeptidase that cleaves aminoacyl proline
dipeptides from the N terminus of polypeptides. In PA14 pepP
appears to be the second gene in a 5 gene operon comprised of
PA5225, a hypothetical protein, pepP, ubiH a ubiquinone
biosynthetic enzyme, PA5225 another hypothetical protein, and
terminating with PA5221, an ORF with homology to E. coli visC a
pyridine nucleotide-disulphide oxidoreductase in the ubiH family.
B) Four MAR2xT7 alleles of pepP display highly attenuated C.
elegans killing. C) Transposon mutants in 4/5 genes in the pepP
operon were tested for their effect on virulence (no mutant was
available in PA5221). Mutants in the two downstream genes
tested, ubiH and PA5222 exhibited wild-type levels of virulence
whereas the single mutant in the upstream PA5225 had a modest
attenuation of virulence (compared to pepP) that might be due to
effects on pepP expression. pepP mutant #31097 produced elevated
levels of pyocyanin and had somewhat reduced swimming ability,
although swarming was normal on both SK and LB (Table 2). The
PepP proline aminopeptidase could function in utilization of
exogenous peptides as nutrients, degradation of proteins or protein
maturation, perhaps of a specific substrate relevant to virulence.
There is a precedent for aminopeptidase function being linked to
virulence associated phenotypes. P. aeruginosa PepA was shown to
be involved in the regulation of alginate biosynthesis [100].
(TIF)
Figure S6 Mutations in cold shock domain (CSD)
protein PA0456 are virulence-attenuated in C. elegans
but mutations in four other CSD proteins do not affect
virulence. A) PA0456 is most likely a single gene transcription
unit. PA0456 (previously annotated as cspB in the PA14 genome)
contains a canonical cold shock domain (CSD) and is homologous
to other CSD proteins (57% identical to the major E. coli cold
shock protein, CspA, and 65% to B. subtilis CspB as determined by
BLASTP). Although the first cold shock proteins (Csps), a
conserved family of small mostly acidic proteins that bind single
stranded DNA and RNA, were identified as major proteins
induced upon temperature downshift, some members of the family
are not induced upon cold shock and many are implicated in other
cellular functions [101]. B) Three independent MAR2xT7
transposon insertions in PA0456 have attenuated virulence in C.
elegans. C) Transposon insertion mutants in four additional CSD
containing genes (capB PA3266, PA0961, cspD PA2622 and
PA1960) have wild-type virulence in C. elegans. Five additional
CSD-containing homologs of PA0456 (PA3266, PA1159, PA0961,
PA2622, PA1960) were identified by BLASTP against the PA14
protein database with 76, 66, 62, 54 and 41% identity to PA0456
respectively; all 5 contain a CSD as analyzed by Prosite and
transposon insertion mutants were available in 4/5 of these genes.
Among the CSD containing proteins tested, PA0456 appears to be
unique in its role in virulence, suggesting that the cold shock
response per se is most likely not required for virulence of PA14.
PA14 PA0456 has been reported to be regulated by quorum
sensing [102], and in keeping with these findings PA0456
exhibited defects in quorum sensing regulated phenotypes; the
PA0456 mutant had reduced pyocyanin production and swarming
motility (Table 2).
(TIF)
Figure S7 KinB (PA5484) sensor kinase is required for
PA14 virulence in C. elegans. KinB negatively regulates
alginate production and has been recently shown to be required
for virulence in zebrafish embryos and mice [86,103]. A) kinB and
its cognate response regulator algB form a two gene operon. B)
Two MAR2xT7 transposon alleles in kinB (as well as an in-frame
deletion of kinB described in Chand et al., data not shown) are
reduced in virulence. C) Transposon mutants in algB (and an in-
frame deletion of algB described in Chand el al., data not shown)
exhibited wild-type virulence in C. elegans, paralleling their lack of
phenotype in zebrafish [86].
(TIF)
Figure S8 Mutations in putative transcriptional regula-
tor PA14_27700 and possible ECF sigma factor
PA14_27690 are virulence-attenuated in C. elegans. A)
PA14_27700, a Crp/FNR-type transcriptional regulator that
appears to have no homologue in PA01 [32], is located 264 bp
downstream of PA2817 and 66 upstream of PA14_26790, a FecI-
like extracytoplasmic function (ECF) sigma that also has no PA01
homologue. It is unclear whether PA14_27700 and PA14_26790
form an operon. B) Multiple MAR2xT7 insertions in both
PA14_27700 and PA14_27690 are attenuated in virulence.
Although not initially identified in our screen, mutants in
PA14_26790 have a strong virulence-attenuated phenotype like
PA14_27700. ECF sigma factors, to which PA14_26790 has
homology, are commonly co-transcribed with a regulatory anti-
sigma factor and the ECF sigma factor and its regulatory anti-
sigma factor frequently play an important role in adaptation to the
external environment [104]. Canonical transmembrane anti-sigma
factors have a small cytoplasmic regulatory/inhibitory domain
linked by a transmembrane domain to a C-terminus sensory
domain that resides in the periplasm. PA14_27700 has neither a
signal sequence nor a transmembrane domain suggesting that it
functions in the cytoplasm. However, most anti-sigma factors are
poorly conserved at the sequence level and there are anti-sigma
factors that sense cytoplasmic stimuli. PA14_27700 #32578,
although attenuated in virulence, does not exhibit any obvious
defects in pigment production or motility in our assays (Table 2).
(TIF)
Figure S9 The virulence-attenuated phenotype of
MAR2xT7 insertions in putative enoyl-CoA hydratase
isomerase PA0745 is recapitulated by an in-frame
deletion and is not dependent on pyoverdine production.
A) PA0745, a putative enoyl-CoA hydratase isomerase, is the third
gene of what is most likely a 5 gene operon: PA0747 a probable
aldehyde dehydrogenase, PA0746 a putative acyl-CoA dehydro-
genase, PA0745, PA0744 another putative enoyl-CoA hydratase/
isomerase, and PA0743 a probable 3-hydroxyisobutyrate dehy-
drogenase. B) Insertions in PA0745 exhibit a virulence-attenuated
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putative operon for which MAR2xT7 mutants were available,
exhibited wild-type levels of virulence. C) The virulence-
attenuated phenotype of an in-frame deletion mutant of PA0745
is complemented by expression of the entire operon (PA0747-
PA0743) in trans. The operon was expressed under its own
promoter; PA14 DNA from genome position 4851671–4848075
was cloned in Pseudomonas vector pucP19 [105]. D) A defect in
pyoverdine production in PA0745 mutants (Table 2) is not the
cause of the PA0745 avirulent phenotype. Pyoverdine biosynthetic
mutants pvdA and pvdD show minimal to no attenuation of
virulence. It has been suggested that PA0745 enoyl-CoA hydratase
isomerase may function in the production of cis-2-decenoic acid, a
fatty acid signal responsible for inducing biofilm dispersal, due to
its weak homology to RpfF which produces cis-11-methyl-2-
dodecenoic acid, the diffusible soluble factor (DSF) required for
virulence in Xanthomonas campestris [106,107]. However, PA0745
and X. campestris paaF (required for the breakdown of phenlyacetic
acid) are reciprocal top BLASTP hits with 65% identity over 95%
of the protein. The putative enzymatic functions of the genes in
the PA0745 operon suggests that this operon may collectively
synthesize or degrade an as yet unidentified product/products that
affect siderophore production, control of swarming, and virulence
in P. aeruginosa.
(TIF)
Figure S10 Transposon mutants in transcriptional
regulator vqsR, but not genes in the adjacent down-
stream operon, are attenuated in virulence. VqsR
(PA2591) is a LuxR type transcriptional regulator that controls
expression of quorum sensing and virulence genes. A vqsR mutant
of P. aeruginosa strain TB has been shown to be impaired in
homoserine lactone production and is attenuated in a liquid C.
elegans killing assay that occurs over a period of hours, similar in
kinetics to toxin mediated PA14 ‘‘fast-killing’’ [108]. A) P.
aeruginosa PA14 vqsR appears to be transcribed as an individual
ORF; it is located 120 bp upstream of an operon that encodes two
conserved hypothetical proteins, PA2590 a putative outer
membrane receptor protein and PA2589 a possible permease. B)
Two MAR2xT7 vqsR transposon mutants have reduced virulence
in C. elegans.C )MAR2xT7 mutants in the operon adjacent to and
downstream of vqsR (PA2590 and PA2589) are as virulent as WT
PA14. In keeping with its role in quorum sensing, the spectrum of
pigment and motility defects of a PA14 vqsR mutant paralleled
those of lasR in our assays; the vqsR mutant was defective in both
pyocyanin production and swarming, and displayed slightly
reduced twitching (data not shown).
(TIF)
Figure S11 Glutamate-cysteine ligase (gshA) is required
for full virulence of PA14. A) gshA (PA5203) is a single gene
transcription unit. B) Four MAR2xT7 transposon insertions in gshA
are virulence-attenuated. Mutations in gshA and gshB (PA0407)
exhibit a similar degree of attenuation suggesting that production
of glutathione may be required for WT levels of virulence (see
Figure 5D).
(TIF)
Figure S12 Nine virulence-attenuated mutants exhibit
normal growth. Cultures were diluted from overnight saturated
cultures to 10
4 CFU/ml in M63 minimal media and grown at
37uC on a rotating wheel. At the indicated times, samples were
taken of each culture, diluted and plated on LB plates. Plates were
incubated overnight and colonies were counted the next day. A)
Growth of virulence-attenuated MAR2xT7 mutants pchH #23790,
PA14_27700 #32578, PA2550 #34827, pchI #35711, PA0456
#36116, clpA #39351, PA1216 #47923, vqsR #52787. B) Growth
of PA0745 in-frame deletion mutant.
(TIF)
Figure S13 PA14 genes required for virulence in C.
elegans were classified according to the breadth of their
phylogenetic distribution across sequenced prokary-
otes. A) Phylogenetic tree indicating breadths of phylogenetic
distribution (or phylostrata) from 0, the narrowest breadth
corresponding to PA14-specific genes, and 1 corresponding to
genes shared found only in other strains of P. aeruginosa, to 6, the
root of the tree and the broadest breadth, corresponding to genes
distributed across eubacteria and archea. Phylogenetic breadths
were assigned to PA14 genes corresponding to the parent node
uniting all the child taxa to which all orthologs of a particular gene
are found. B) The percentages of P. aeruginosa strain PA14 genes,
PA14-NR set genes, and primary, secondary, tertiary, auxotroph,
and VFDB set genes within each phylogenetic breadth is shown.
The primary, secondary, tertiary, and auxotroph gene sets were
apparently underrepresented in the breadths 0, 1, 2, and 3, but
without statistical significance after multiple comparison correc-
tion using false discovery rate (q,=0.05) due to the small number
of genes involved. Among the auxotrophs, genes of breadth 4 were
underrepresented (p-value=0.0027) and 6 overrepresented (p-
value=1.2610
28). Among VFDB genes, genes of breadth 3 were
overrepresented (p-value=1.22610
28) and breadth 6 were
underrepresented (p-value=7.92610
211).
(TIF)
Table S1 Numerical accounting of virulence-attenuated
PA14 transposon mutants identified in the primary,
secondary and tertiary screens. (*) The 5754 mutants
screened was the NR library (5850 insertion mutants) minus one
96-well plate of known slow growing mutants. Note that for the
primary and secondary screen, the number of mutants obtained is
presented; some genes were represented by multiple mutants and a
few mutants were in intergenic regions (see text). In the tertiary
screen, the number of genes is designated.
(DOCX)
Table S2 Auxotrophic and slow-growing mutants iden-
tified in the primary screen for virulence-attenuated
mutants.
(XLSX)
Table S3 Virulence-attenuated mutants identified in
the primary screen minus auxotrophs from Table S2.
(XLSX)
Table S4 PA14 virulence-attenuated mutants identified
in the secondary screen.
(XLSX)
Table S5 Mutants in 58 genes tested in the tertiary
screen for attenuation of virulence.
(XLSX)
Table S6 41 virulence-attenuated genes shown in
Figure 2.
(XLSX)
Table S7 Contains the following sheets showing totals
and statistics for Figures 7, 8, and S13. This spreadsheet
contains total counts, and percentages for comparisons across the
various gene sets: the PA14 genome, the NR set, and the primary,
secondary, tertiary, auxotroph, and VFDB sets. Fisher exact tests
were performed relative to gene totals the NR set, and left, right,
and two-tailed probabilities (p-values) indicating underrepresenta-
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for the primary, secondary, tertiary, auxotroph, and VFDB sets.
FDR q-values are calculated only for the left and right
probabilities, and are shown below the corresponding left and
right probabilities. Results with statistical significance after FDR
correction are shown in red font. Cells are colored according to
the coloring of the corresponding legends in Figure 7 and Figure 8.
Sheet ‘‘A. Core vs Auxiliary Genes’’. This sheet contains the total
counts and percentages of Core and Auxiliary genes across the
various gene sets (see above). These data are presented graphically
in Figure 7A with corresponding coloring of bars. Sheet ‘‘B.
Predicted vs Non-Island’’. This sheet contains the total counts and
percentages of ‘‘predicted island’’ and ‘‘non-island’’ genes across
the various gene sets. These data are presented graphically in
Figure 7B. Sheet ‘‘C. Known Island vs Non-Island’’. This sheet
contains the total counts and percentages of ‘‘known island’’ and
‘‘non-island’’ genes across the various gene sets. These data are
presented graphically in Figure 7C. Sheet ‘‘D. Phylogenetic
Breadths’’. This sheet contains the total counts and percentages of
genes with various breadths of phylogenetic distribution, or
phylostrata across the various gene sets. These data are presented
graphically in Figure S13. Sheet ‘‘E. PGS and HFBP’’. This sheet
contains the total counts and percentages of genes within the
Pseudomonas-genus-specific (PGS), in the HFBP set, and in non-
PGS non-HFBP (‘‘All Others’’), across the various gene sets. These
data are presented graphically in Figure 8.
(XLS)
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